TUBB4A-related Neurologic Disorder

Mendelian MONDO:0800470 Pathograph 37 Show in embeddings browser hereditary neurological disease movement disorder

TUBB4A-related neurologic disorder is an autosomal dominant allelic spectrum that spans pediatric-onset hypomyelinating and neurodegenerative disease and juvenile- or adult-onset dystonia. Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC; hypomyelinating leukodystrophy 6) is an ontology-grounded subtype of this spectrum, not a synonym for the umbrella disorder. Its white-matter and grey-matter abnormalities are parallel features: hypomyelination may be diffuse or mild and focal, while caudate and putaminal atrophy can be absent even after years of follow-up. DYT-TUBB4A (historically DYT4 or whispering dysphonia) is a distinct, usually inherited movement-disorder presentation with prominent laryngeal and generalized dystonia and typically normal neuroimaging. The molecular effects are allele specific. The studied H-ABC p.Arg2Trp and p.Asp249Asn substitutions have antimorphic effects on microtubule assembly, whereas the DYT-associated p.Arg2Gly substitution produced neuronal morphology changes without a prominent microtubule-dynamics defect and p.Gln424His showed increased growth dynamics consistent with gain of function. The p.Cys239Phe and p.Arg262His H-ABC alleles expand the clinical and imaging spectrum but have not been assigned those tested functional mechanisms. This heterogeneity is why no single functional-impact category or variant origin is asserted for the umbrella disorder.

Ask OpenScientist

Ask a research question about TUBB4A-related Neurologic Disorder. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
7
Pathophys.
20
Phenotypes
2
Gaps
37
Pathograph
1
Genes
8
Medical Actions
2
Subtypes
2
Models
10
References
👪

Inheritance

1
Autosomal dominant inheritance HP:0000006
A heterozygous pathogenic TUBB4A variant is sufficient across the spectrum, but origin differs by subtype. H-ABC is usually simplex and de novo; parental somatic mosaicism has been documented, so recurrence risk is not zero after negative parental blood testing. DYT-TUBB4A is usually inherited and was mapped in a multigenerational family. An affected individual has a 50% chance of transmitting the variant to each child.
Autosomal dominant inheritance
Show evidence (5 references)
PMID:27809427 SUPPORT Other
"TUBB4A-related neurologic disorders are inherited in an autosomal dominant manner."
GeneReviews states the inheritance mode for the whole phenotypic spectrum.
PMID:27809427 SUPPORT Other
"Each child of an individual with a TUBB4A-related neurologic disorder has a 50% chance of inheriting the TUBB4A pathogenic variant."
GeneReviews directly supports the 50% transmission risk for a child of an affected heterozygous individual. This is distinct from the recurrence risk after an apparently de novo variant or parental mosaicism.
PMID:27809427 SUPPORT Other
"The diagnosis is established in a proband with characteristic clinical and/or brain MRI findings and a heterozygous TUBB4A pathogenic variant identified by molecular genetic testing."
Confirms that a single heterozygous variant is sufficient for diagnosis.
+ 2 more references
◆

Subtypes

2
Hypomyelination with atrophy of the basal ganglia and cerebellum (HLD6) MONDO:0012905
TUBB4A hgnc:20774 HUGO Gene Nomenclature Committee (hgnc) Relation: this subtype is caused by variation in this gene This subtype is caused by variation in TUBB4A (hgnc:20774). hgnc:20774 is a gene from the HUGO Gene Nomenclature Committee.
The ontology-grounded H-ABC/HLD6 subtype, typically pediatric onset with progressive pyramidal, extrapyramidal, cerebellar, and bulbar dysfunction. Hypomyelination and caudate, putaminal, or cerebellar atrophy are important imaging features but are variable over time and by allele; p.Arg262His was associated with typical clinical H-ABC without caudate or putaminal atrophy after seven years. MONDO:0012905 is retained only here and does not make the umbrella disorder synonymous with a leukodystrophy.
Show evidence (2 references)
PMID:41566774 SUPPORT Human Clinical
"The recurring variant p.Asp249Asn (D249N) presents in infancy with dystonia, communication deficits, and loss of ambulation during the first decade of life."
Characterizes the recurrent H-ABC allele and its clinical course.
PMID:24706558 SUPPORT Human Clinical
"The second novel mutation, p.R262H, was found in a patient with a typical clinical presentation for H-ABC, but with a novel neuroimaging phenotype, given the absence of atrophy of the putamen and caudate nucleus despite 7 years of follow-up."
Establishes that the eponymous basal-ganglia atrophy is not obligatory.
DYT-TUBB4A (DYT4 dystonia, whispering dysphonia)
TUBB4A hgnc:20774 HUGO Gene Nomenclature Committee (hgnc) Relation: this subtype is caused by variation in this gene This subtype is caused by variation in TUBB4A (hgnc:20774). hgnc:20774 is a gene from the HUGO Gene Nomenclature Committee.
Juvenile- or adult-onset dystonia, historically DYT4, commonly featuring laryngeal dystonia and whispering dysphonia. Familial inheritance is well documented, and neuroimaging can be normal. No subtype ontology term is assigned because none is available in the frozen local term cache.
Show evidence (2 references)
PMID:27809427 SUPPORT Other
"Milder presentations are associated with juvenile or adult onset, including a typical adult-onset dystonia characterized as DYT-TUBB4A."
Defines the mild adult-onset dystonia pole of the TUBB4A spectrum.
PMID:23595291 SUPPORT Human Clinical
"A mutation in TUBB4 causes DYT4 dystonia in this Australian family with so-called whispering dysphonia, and other mutations in TUBB4 may contribute to spasmodic dysphonia."
Provides the causal familial evidence and characteristic voice phenotype.
?

Discussions and Knowledge Gaps

2
Why do TUBB4A variants in the same gene produce either isolated adult-onset dystonia or infantile hypomyelinating leukodystrophy, and is a single functional_impact_category ever correct for this locus?
KNOWLEDGE GAP OPEN gap_tubb4a_pleiotropy_mechanism
Attached to
pathophysiology#Altered Beta-Tubulin 4A (TUBB4A) Function pathophysiology#H-ABC Antimorphic Microtubule Dysfunction pathophysiology#DYT-TUBB4A-Associated Neuronal Dysfunction
TUBB4A is the clearest pleiotropy problem in the tubulin family. Two observations pull in different directions. On one hand, the dystonia-causing variants (p.R2G, p.Q424H) and the H-ABC-causing variants (p.R2W, p.D249N) have demonstrably divergent effects on microtubule polymerization and on incorporation into the network in disease-relevant oligodendrocytes - which argues the two poles are mechanistically distinct, not one mechanism at two doses. Note the pointed detail that R2G and R2W affect the SAME residue and fall on opposite clinical poles. On the other hand, an allelic mouse series shows severity correlating cleanly with mutant expression and preserved wild-type tubulin, which is exactly what a single dose-dependent mechanism would look like. Both cannot be the whole story. The authors of the divergence study are careful to say the mechanisms explain the pleiotropy only "partially". Until this resolves, this entry records functional_impact_category as UNKNOWN rather than picking a value that would be wrong for half the alleles, and curators should not import a mechanism class from another tubulin gene by analogy.
Show evidence (3 references)
PMID:35275727 SUPPORT In Vitro
"Here, we investigated whether TUBB4A mutations causing either DYT-TUBB4A (p.R2G and p.Q424H) or H-ABC (p.R2W and p.D249N) exhibit differential effects at the molecular and cellular levels."
Names the allele pairs, including the two different substitutions at residue 2 that fall on opposite clinical poles.
PMID:35275727 SUPPORT In Vitro
"In conclusion, for most of the examined variants, we deciphered potential molecular disease mechanisms that may lead to the diverse clinical manifestations and phenotype severity across and within each TUBB4A-related disease."
The authors' own hedging - potential mechanisms, most variants - which is why this stays an open gap.
PMID:41566774 SUPPORT Model Organism
"disease severity correlates with the expression of mutant Tubb4a and relative preservation of wild-type tubulin"
The dose-dependent evidence that pulls against a purely allele-specific mechanism model.
Can a Tubb4a-suppressing ASO reach cerebellar granule neurons, and if not, does the cerebellar arm of H-ABC remain untreated by an otherwise effective therapy?
KNOWLEDGE GAP OPEN gap_tubb4a_cerebellar_aso_gap
Attached to
pathophysiology#Basal Ganglia and Cerebellar Neurodegeneration
The ASO proof-of-concept is striking on the myelin arm - extended lifespan, improved motor phenotypes, fewer seizures, preserved oligodendrocytes and myelin. But the authors flag one failure plainly: the ASO does not reach cerebellar granule neurons by any route of brain administration they tried. That matters more here than it would for a disorder with a single mechanism, because this entry curates cerebellar degeneration as a parallel arm rather than as a consequence of demyelination - the mouse work shows both glial and neuronal degeneration. If the arms are truly parallel, an intervention that rescues myelin and misses the cerebellum treats part of the disease, and the residual cerebellar phenotype would only become visible once the animals live long enough to show it. Resolving this needs either a delivery route that reaches granule neurons or long-term outcome data in treated animals with cerebellar-specific readouts.
Show evidence (2 references)
PMID:41566774 SUPPORT Model Organism
"A major limitation we noted is that ASOs fail to target cerebellar granule neurons even with multiple routes of administration in the brain."
The stated delivery failure that defines this gap.
PMID:32463361 SUPPORT Model Organism
"Additionally, a significant loss occurs in the cerebellar granular neurons and striatal neurons in Tubb4aD249N/D249N mice."
Cerebellar granule neurons are specifically among the cells lost, which is what makes an ASO that cannot reach them consequential.
⚙

Pathophysiology

7
Altered Beta-Tubulin 4A (TUBB4A) Function
Heterozygous missense variants alter the brain-enriched beta-tubulin 4A isotype, but this locus-level trigger does not imply one downstream mechanism. H-ABC and DYT-associated alleles have divergent cellular effects, so the graph immediately separates an H-ABC oligodendrocyte/grey-matter branch from a cautious DYT neuronal branch.
TUBB4A hgnc:20774 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves TUBB4A (hgnc:20774). hgnc:20774 is a gene from the HUGO Gene Nomenclature Committee.
Genetic context allele_type: missense zygosity: HETEROZYGOUS functional_impact_category: UNKNOWN
UNKNOWN is deliberate at the umbrella level. p.Arg2Trp and p.Asp249Asn were interpreted as antimorphic, p.Gln424His showed a gain-of-function growth pattern, and p.Arg2Gly showed no prominent dynamics change. p.Cys239Phe and p.Arg262His are established H-ABC alleles without equivalent functional testing in the cached evidence. Variant origin is omitted because H-ABC is usually de novo whereas DYT-TUBB4A is often inherited.
Downstream
H-ABC Antimorphic Microtubule Dysfunction The studied p.Arg2Trp and p.Asp249Asn H-ABC alleles reduce incorporation and microtubule growth and were interpreted as antimorphic.
DYT-TUBB4A-Associated Neuronal Dysfunction DYT alleles act through a distinct neuronal route, but p.Arg2Gly and p.Gln424His do not share one experimentally established molecular effect.
Show evidence (2 references)
PMID:35275727 SUPPORT In Vitro
"Using live-cell imaging of disease-relevant oligodendrocytes and total internal reflection fluorescence microscopy of whole-cell lysates, we observed divergent impact on microtubule polymerization and microtubule integration, partially reflecting the observed pleiotropy."
Establishes both the molecular lesion (perturbed polymerization and incorporation) and its non-uniformity across disease-causing alleles.
PMID:35275727 SUPPORT Computational
"Moreover, in silico simulations demonstrated that the mutants rarely adopted a straight heterodimer conformation in contrast to wild type."
Structural evidence for allele-specific conformational effects; it is not used to assign one functional-impact category across the spectrum.
H-ABC Antimorphic Microtubule Dysfunction
In the studied H-ABC alleles p.Arg2Trp and p.Asp249Asn, mutant heterodimers incorporate less efficiently, grow more slowly, and can act as steric blocks during assembly. This antimorphic mechanism is limited to those tested alleles; it is not assigned to p.Cys239Phe or p.Arg262His merely because they also cause H-ABC.
TUBB4A hgnc:20774 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves TUBB4A (hgnc:20774). hgnc:20774 is a gene from the HUGO Gene Nomenclature Committee.
Genetic context allele_type: missense zygosity: HETEROZYGOUS functional_impact_category: DOMINANT_NEGATIVE
Applies to the experimentally studied H-ABC p.Arg2Trp and p.Asp249Asn substitutions. The functional category records their reported antimorphic behavior and is not a spectrum-wide assertion.
Animal models
Tubb4a D249N allelic mouse series Mouse recapitulates Models the recurrent human H-ABC allele, and the allelic series isolates the mutant-to-wild-type ratio as the severity determinant.
Downstream
Oligodendrocyte Dysfunction and Myelin Failure Severe microtubule-dynamics disruption impairs oligodendrocyte maturation and myelin production.
Basal Ganglia and Cerebellar Neurodegeneration H-ABC also has a parallel neuronal/grey-matter arm, but its route from the allele-specific tubulin defect is not resolved.
Show evidence (2 references)
PMID:35275727 SUPPORT In Vitro
"Therefore, we suggest an antimorphic conformational change in the H-ABC mutants, but not to a complete loss of function of the affected tubulin heterodimers. Hence, the H-ABC mutants might act as steric hindrances during microtubule assembly."
Supplies the antimorphic interpretation for the tested H-ABC variants.
PMID:35275727 SUPPORT In Vitro
"On the other side of the phenotypic spectrum, the H-ABC-causing mutations p.R2W and p.D249N showed significantly reduced growth dynamics."
Directly identifies the two H-ABC alleles to which the reduced-growth claim applies.
DYT-TUBB4A-Associated Neuronal Dysfunction
The DYT-associated p.Arg2Gly allele altered neuronal morphology while leaving tubulin quantity, polymerization, oligodendrocyte morphology, and myelin-gene expression unchanged in the reported cellular study. p.Gln424His instead increased microtubule growth dynamics, consistent with gain of function. These allele-specific observations support a neuronal branch independent of H-ABC myelin failure, but do not yet establish a single intervening pathway.
neuron CL:0000540 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neuron (CL:0000540). CL:0000540 is a cell type from the Cell Ontology.
Downstream
Dystonia The neuronal defect is associated with generalized dystonia.
Laryngeal Dystonia Laryngeal involvement produces the characteristic whispering dysphonia.
Dysphonia Voice impairment is a cardinal manifestation of DYT-TUBB4A.
Show evidence (2 references)
PMID:28973395 SUPPORT In Vitro
"Thus, the DYT4 mutation that leads to phenotypes attributable to neuronal dysfunction results in altered neuronal morphology, but with unchanged tubulin quantity and polymerization, with normal oligodendrocyte morphology and myelin gene expression."
Supports a neuronal, non-myelin route for p.Arg2Gly without asserting a microtubule-dynamics defect.
PMID:35275727 SUPPORT In Vitro
"When compared to WT TUBB4A, the dystonia-associated mutants showed either no differences (p.R2G) or considerably increased growth dynamics (p.Q424H)."
Preserves the different functional results for the two tested DYT alleles.
Oligodendrocyte Dysfunction and Myelin Failure
In H-ABC, oligodendrocyte differentiation, process formation, and myelin production are impaired. The D249N allelic mouse series identifies Mbp mRNA transport from the oligodendrocyte soma to the sheath as one vulnerable microtubule-dependent function. The A302T taiep rat instead shows increased tubulin post-translational modifications associated with stability, warning that the direction of microtubule disturbance and the neuronal contribution are allele- and model-specific rather than universal.
oligodendrocyte CL:0000128 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves oligodendrocyte (CL:0000128). CL:0000128 is a cell type from the Cell Ontology.
myelination GO:0042552 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased myelination (GO:0042552). GO:0042552 is a biological process from the Gene Ontology. ↓ DECREASED microtubule-based transport GO:0099111 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased microtubule-based transport (GO:0099111). GO:0099111 is a biological process from the Gene Ontology. ↓ DECREASED
cerebral white matter UBERON:0002316 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cerebral white matter, annotated with white matter (UBERON:0002316). UBERON:0002316 is an anatomical location from the Uberon multi-species anatomy ontology.
Animal models
Tubb4a D249N allelic mouse series Mouse rescues ASO treatment prevents myelin and oligodendrocyte loss and preserves Mbp mRNA transport, demonstrating the myelin arm is reversible in the model if the mutant burden is lowered early.
Downstream
CNS Hypomyelination Failure of oligodendrocyte myelin production produces the hypomyelination seen on MRI.
Progressive Motor and Bulbar Decline Loss of myelinated-tract function contributes to the H-ABC motor decline, alongside the parallel grey-matter arm.
Show evidence (2 references)
PMID:41566774 SUPPORT Model Organism
"Furthermore, the microtubule function of Mbp mRNA transport from the OL soma to the myelin sheath is retained."
Identifies the specific microtubule-dependent oligodendrocyte function at stake - Mbp mRNA transport to the sheath - by showing it is preserved when the mutant transcript is suppressed.
PMID:42044700 SUPPORT Model Organism
"Compared to controls, taiep rats displayed significantly elevated levels of tubulin acetylation and detyrosination within white matter regions."
Animal-model evidence for an oligodendrocyte cytoskeletal defect associated with microtubule stability; it is not classified as an in-vitro result.
Basal Ganglia and Cerebellar Neurodegeneration
H-ABC has a grey-matter arm parallel to hypomyelination. The common pattern includes progressive caudate, putaminal, and cerebellar atrophy, but it is not obligatory: a p.Arg262His patient retained stable caudate and putaminal size over seven years, and mild thalamic atrophy occurred in other followed patients. The D249N mouse shows striatal and cerebellar granule-neuron loss. This node is H-ABC-specific and is not used to explain DYT-TUBB4A, which can have normal neuroimaging.
neuron CL:0000540 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neuron (CL:0000540). CL:0000540 is a cell type from the Cell Ontology.
basal ganglia UBERON:0002420 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in basal ganglia, annotated with basal ganglion (UBERON:0002420). UBERON:0002420 is an anatomical location from the Uberon multi-species anatomy ontology. cerebellum UBERON:0002037 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cerebellum (UBERON:0002037). UBERON:0002037 is an anatomical location from the Uberon multi-species anatomy ontology.
Animal models
Tubb4a H-ABC mutant mouse (glial and neuronal degeneration) Mouse recapitulates Reproduces neuronal degeneration alongside the glial phenotype.
Downstream
Dystonia Striatal pathology plausibly contributes to H-ABC dystonia, but the patient-level route is not demonstrated.
Ataxia Cerebellar degeneration produces ataxia, intention tremor and dysmetria.
Cerebellar Atrophy The structural correlate of the cerebellar arm.
Abnormal Basal Ganglia Morphology The structural correlate of the caudate and putaminal arm, with documented exceptions and no claim of universal thalamic sparing.
Progressive Motor and Bulbar Decline Extrapyramidal and cerebellar degeneration contribute to the progressive decline in motor and bulbar function.
Show evidence (3 references)
PMID:32463361 SUPPORT Model Organism
"Additionally, a significant loss occurs in the cerebellar granular neurons and striatal neurons in Tubb4aD249N/D249N mice."
Reports measured loss of cerebellar granule and striatal neurons, the neuronal arm of this node.
PMID:27809427 SUPPORT Other
"A subset of individuals with late-infantile onset progress to hypomyelination with atrophy of the basal ganglia and cerebellum."
Documents the structural atrophy of basal ganglia and cerebellum that occurs in a subset of the spectrum.
PMID:24706558 SUPPORT Human Clinical
"The second novel mutation, p.R262H, was found in a patient with a typical clinical presentation for H-ABC, but with a novel neuroimaging phenotype, given the absence of atrophy of the putamen and caudate nucleus despite 7 years of follow-up."
Directly prevents the common atrophy pattern from being modeled as obligatory or diagnostic.
CNS Hypomyelination
Deficient CNS myelin is characteristic of H-ABC and other pediatric TUBB4A presentations, but severity varies. In the three longitudinally imaged H-ABC patients in PMID:24706558 it was generalized in two and focal and milder in one. That three-patient observation is not converted into an obligatory frequency claim for H-ABC or the umbrella disorder.
cerebral white matter UBERON:0002316 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cerebral white matter, annotated with white matter (UBERON:0002316). UBERON:0002316 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
CNS Hypomyelination Phenotype The MRI-defined phenotype itself.
Show evidence (2 references)
PMID:27809427 SUPPORT Other
"Brain imaging at the time of developmental loss typically identifies hypomyelination."
Establishes hypomyelination as the characteristic imaging finding at the point of clinical decline.
PMID:24706558 SUPPORT Human Clinical
"Hypomyelination was found in all patients and was generalized in Patients 1 (Fig. 1B,D) and 2 (Fig. 1F,H), but focal and milder in Patient 3."
Establishes variable extent in the three longitudinally studied patients; it does not establish a population-wide obligatory frequency.
Progressive Motor and Bulbar Decline
The H-ABC clinical endpoint combines four systems: pyramidal tracts (spasticity, brisk reflexes, Babinski), extrapyramidal system (rigidity, dystonia, choreoathetosis, oculogyric crisis, perioral dyskinesia), cerebellum (ataxia, intention tremor, dysmetria) and bulbar function (dysarthria, dysphonia, swallowing). It intentionally does not conform to the white-matter module because the grey- and white-matter arms both contribute.
Downstream
Spasticity Pyramidal tract involvement.
Dysarthria Bulbar involvement.
Dysphonia Voice impairment from bulbar involvement in H-ABC.
Dysphagia Progressive bulbar involvement impairs swallowing.
Rigidity Extrapyramidal involvement produces rigidity.
Choreoathetosis Extrapyramidal involvement produces choreoathetosis.
Intention Tremor Cerebellar involvement produces intention tremor.
Dysmetria Cerebellar involvement produces dysmetria.
Developmental Regression Loss of previously acquired milestones is the presenting event in the late-infantile form.
Loss of Ambulation Motor decline typically costs independent walking.
Hypotonia Hypotonia occurs in severe pediatric presentations.
Seizures Seizures occur in a minority of H-ABC patients.
Nystagmus The route to the oculomotor finding is not established.
Sensorineural Hearing Impairment The route to hearing impairment is not established.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"Progressive neurologic findings reflect involvement of the pyramidal tracts (spasticity, brisk deep tendon reflexes, and Babinski sign), extrapyramidal system (rigidity, dystonia, choreoathetosis, oculogyric crisis, and perioral dyskinesia), cerebellum (ataxia, intention tremor, dysmetria), and..."
Enumerates the four systems whose progressive involvement constitutes the clinical decline.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for TUBB4A-related Neurologic Disorder Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

20
Digestive 1
Dysphagia HP:0002015 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dysphagia (HP:0002015). HP:0002015 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"Swallowing dysfunction may require gastrostomy tube placement for feeding."
Establishes swallowing dysfunction as the phenotype requiring feeding support.
Ear 1
Sensorineural Hearing Impairment HP:0000407 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sensorineural hearing impairment (HP:0000407). HP:0000407 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24706558 SUPPORT Human Clinical
"sensorineural hearing loss in 14%, and seizures in 18%"
Establishes sensorineural hearing impairment in H-ABC.
Context-specific annotations (1)
H-ABC 14%
Exact reviewed H-ABC frequency, 14% of 30 published patients.
Show evidence (1 reference)
PMID:24706558 SUPPORT Human Clinical
"sensorineural hearing loss in 14%, and seizures in 18%"
Records the exact H-ABC hearing-impairment frequency.
Eye 1
Nystagmus HP:0000639 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Nystagmus (HP:0000639). HP:0000639 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24706558 SUPPORT Human Clinical
"nystagmus in 33%, decreased vision or poor visual tracking in 27%, sensorineural hearing loss in 14%, and seizures in 18%"
Establishes nystagmus in the reviewed H-ABC cohort.
Context-specific annotations (1)
H-ABC 33%
Exact reviewed H-ABC frequency, 33% of 30 published patients.
Show evidence (1 reference)
PMID:24706558 SUPPORT Human Clinical
"nystagmus in 33%, decreased vision or poor visual tracking in 27%, sensorineural hearing loss in 14%, and seizures in 18%"
Records the exact H-ABC nystagmus frequency.
Musculoskeletal 3
Spasticity HP:0001257 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Spasticity (HP:0001257). HP:0001257 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"pyramidal tracts (spasticity, brisk deep tendon reflexes, and Babinski sign)"
Lists spasticity among the pyramidal findings.
Context-specific annotations (1)
H-ABC 100%
Exact reviewed H-ABC frequency, 100% of 30 published patients.
Show evidence (1 reference)
PMID:24706558 SUPPORT Human Clinical
"Spasticity was present in 100% of patients, while ataxia was present in 87%, choreoathetosis in 45%, dystonia in 88%, rigidity in 69%, and dysarthria in 93%"
Records the exact H-ABC spasticity frequency on HP:0001257; the narrower lower-limb spasticity term is not used.
Hypotonia HP:0001252 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypotonia (HP:0001252). HP:0001252 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"An early-infantile presentation is typically associated with hypomyelination, severe stagnation of developmental milestones, encephalopathy, seizures, and hypotonia."
Lists hypotonia in the early-infantile presentation.
Rigidity HP:0002063 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Rigidity (HP:0002063). HP:0002063 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"extrapyramidal system (rigidity, dystonia, choreoathetosis, oculogyric crisis, and perioral dyskinesia)"
Names rigidity among the extrapyramidal findings.
Context-specific annotations (1)
H-ABC 69%
Exact reviewed H-ABC frequency, 69% of 30 published patients.
Show evidence (1 reference)
PMID:24706558 SUPPORT Human Clinical
"Spasticity was present in 100% of patients, while ataxia was present in 87%, choreoathetosis in 45%, dystonia in 88%, rigidity in 69%, and dysarthria in 93%"
Records the exact H-ABC rigidity frequency.
Nervous System 9
Dystonia HP:0001332 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dystonia (HP:0001332), qualified as course progressive. HP:0001332 is a phenotype from the Human Phenotype Ontology.
Course: PROGRESSIVE
Show evidence (2 references)
PMID:27809427 SUPPORT Other
"extrapyramidal system (rigidity, dystonia, choreoathetosis, oculogyric crisis, and perioral dyskinesia)"
Lists dystonia among the extrapyramidal findings.
PMID:41566774 SUPPORT Human Clinical
"The recurring variant p.Asp249Asn (D249N) presents in infancy with dystonia, communication deficits, and loss of ambulation during the first decade of life."
Documents dystonia as a presenting feature of the recurrent H-ABC allele.
Context-specific annotations (1)
H-ABC 88%
Exact reviewed H-ABC frequency, 88% of 30 published patients.
Show evidence (1 reference)
PMID:24706558 SUPPORT Human Clinical
"Spasticity was present in 100% of patients, while ataxia was present in 87%, choreoathetosis in 45%, dystonia in 88%, rigidity in 69%, and dysarthria in 93%"
Records the exact H-ABC dystonia frequency without applying it to DYT.
Cerebellar Atrophy HP:0001272 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cerebellar atrophy (HP:0001272). HP:0001272 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:27809427 SUPPORT Other
"A subset of individuals with late-infantile onset progress to hypomyelination with atrophy of the basal ganglia and cerebellum."
Documents cerebellar atrophy as part of the H-ABC progression.
PMID:24706558 SUPPORT Human Clinical
"At follow-up, we saw cerebellar atrophy in all patients"
Establishes the follow-up finding without turning a three-patient series into an obligatory subtype frequency.
Ataxia HP:0001251 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Ataxia (HP:0001251). HP:0001251 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"cerebellum (ataxia, intention tremor, dysmetria)"
Lists ataxia among the cerebellar findings.
Context-specific annotations (1)
H-ABC 87%
Exact reviewed H-ABC frequency, 87% of 30 published patients.
Show evidence (1 reference)
PMID:24706558 SUPPORT Human Clinical
"Spasticity was present in 100% of patients, while ataxia was present in 87%, choreoathetosis in 45%, dystonia in 88%, rigidity in 69%, and dysarthria in 93%"
Records the exact H-ABC ataxia frequency.
Dysarthria HP:0001260 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dysarthria (HP:0001260). HP:0001260 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"bulbar function (dysarthria, dysphonia, and swallowing)"
Lists dysarthria and dysphonia among the bulbar findings.
Context-specific annotations (1)
H-ABC 93%
Exact reviewed H-ABC frequency, 93% of 30 published patients.
Show evidence (1 reference)
PMID:24706558 SUPPORT Human Clinical
"Spasticity was present in 100% of patients, while ataxia was present in 87%, choreoathetosis in 45%, dystonia in 88%, rigidity in 69%, and dysarthria in 93%"
Records the exact H-ABC dysarthria frequency.
Developmental Regression HP:0002376 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Developmental regression (HP:0002376). HP:0002376 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"A late-infantile presentation is often characterized by acquisition of developmental milestones including walking or supported ambulation with later onset of regression and dystonia."
Documents the acquire-then-lose trajectory that defines regression here.
Context-specific annotations (1)
H-ABC
H-ABC commonly follows an acquire-then-regress trajectory; no exact frequency is asserted from the available source.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"A late-infantile presentation is often characterized by acquisition of developmental milestones including walking or supported ambulation with later onset of regression and dystonia."
Supports the H-ABC developmental trajectory.
Seizures HP:0001250 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Seizure (HP:0001250). HP:0001250 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"An early-infantile presentation is typically associated with hypomyelination, severe stagnation of developmental milestones, encephalopathy, seizures, and hypotonia."
Lists seizures in the early-infantile presentation.
Context-specific annotations (1)
H-ABC 18%
Exact reviewed H-ABC frequency, 18% of 30 published patients.
Show evidence (1 reference)
PMID:24706558 SUPPORT Human Clinical
"nystagmus in 33%, decreased vision or poor visual tracking in 27%, sensorineural hearing loss in 14%, and seizures in 18%"
Records the exact H-ABC seizure frequency.
Choreoathetosis HP:0001266 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Choreoathetosis (HP:0001266). HP:0001266 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"extrapyramidal system (rigidity, dystonia, choreoathetosis, oculogyric crisis, and perioral dyskinesia)"
Names choreoathetosis among the extrapyramidal manifestations.
Context-specific annotations (1)
H-ABC 45%
Exact reviewed H-ABC frequency, 45% of 30 published patients.
Show evidence (1 reference)
PMID:24706558 SUPPORT Human Clinical
"Spasticity was present in 100% of patients, while ataxia was present in 87%, choreoathetosis in 45%, dystonia in 88%, rigidity in 69%, and dysarthria in 93%"
Records the exact H-ABC frequency on the exact choreoathetosis term.
Abnormal Basal Ganglia Morphology HP:0002134 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormal basal ganglia morphology (HP:0002134), qualified as course progressive. HP:0002134 is a phenotype from the Human Phenotype Ontology.
Course: PROGRESSIVE
Show evidence (2 references)
PMID:24706558 SUPPORT Human Clinical
"In Patients 1 and 2, progressive atrophy of the head of the caudate was noted"
Supports progressive caudate atrophy in two followed patients.
PMID:24706558 SUPPORT Human Clinical
"In Patient 3, however, the size of the putamina and heads of the caudate remained stable between first and follow-up MR studies (Fig. 1J,L)."
Preserves the documented exception to progressive neostriatal atrophy.
Intention Tremor HP:0002080 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Intention tremor (HP:0002080). HP:0002080 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"cerebellum (ataxia, intention tremor, dysmetria)"
Names intention tremor among the cerebellar findings.
Other 5
CNS Hypomyelination Phenotype HP:0003429 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is CNS hypomyelination (HP:0003429). HP:0003429 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"Brain imaging at the time of developmental loss typically identifies hypomyelination."
Reports hypomyelination as the typical imaging finding.
Context-specific annotations (1)
H-ABC
Hypomyelination occurred in all three longitudinal-study patients but ranged from generalized to focal and mild; this small selected series is not converted into a subtype-wide frequency.
Show evidence (1 reference)
PMID:24706558 SUPPORT Human Clinical
"Hypomyelination was found in all patients and was generalized in Patients 1 (Fig. 1B,D) and 2 (Fig. 1F,H), but focal and milder in Patient 3."
Supports H-ABC-specific occurrence and variable extent without an obligatory population-frequency claim.
Loss of Ambulation HP:0002505 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Loss of ambulation (HP:0002505). HP:0002505 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:41566774 SUPPORT Human Clinical
"presents in infancy with dystonia, communication deficits, and loss of ambulation during the first decade of life"
Reports loss of ambulation within the first decade for the recurrent allele.
Dysphonia HP:0001618 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dysphonia (HP:0001618). HP:0001618 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:27809427 SUPPORT Other
"bulbar function (dysarthria, dysphonia, and swallowing)"
Names dysphonia among the bulbar findings.
PMID:23595291 SUPPORT Human Clinical
"A mutation in TUBB4 causes DYT4 dystonia in this Australian family with so-called whispering dysphonia, and other mutations in TUBB4 may contribute to spasmodic dysphonia."
Establishes the DYT-specific voice phenotype.
Laryngeal Dystonia HP:0012049 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Laryngeal dystonia (HP:0012049). HP:0012049 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33084096 SUPPORT Human Clinical
"We report the case of a 44-year-old patient with DYT-TUBB4A with a clinical presentation of disabling progressive dystonia, with a prominent laryngeal, cervical and facial involvement."
Directly establishes prominent laryngeal dystonia in DYT-TUBB4A.
Dysmetria HP:0001310 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dysmetria (HP:0001310). HP:0001310 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"cerebellum (ataxia, intention tremor, dysmetria)"
Names dysmetria among the cerebellar findings.
🧬

Genetic Associations

1
TUBB4A (Causative)
Gene: TUBB4A (beta-tubulin 4A) hgnc:20774 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is TUBB4A (beta-tubulin 4A), annotated with TUBB4A (hgnc:20774). hgnc:20774 is a gene from the HUGO Gene Nomenclature Committee.
Show evidence (3 references)
PMID:35275727 SUPPORT Other
"Mutations in the brain-specific β-tubulin 4A (TUBB4A) gene cause a broad spectrum of diseases, ranging from dystonia (DYT-TUBB4A) to hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC)."
Establishes TUBB4A as causative across the full phenotypic spectrum this entry curates. This framing statement is a literature summary, so OTHER is used rather than HUMAN_CLINICAL.
PMID:24706558 SUPPORT Human Clinical
"A p.C239F mutation was found in one of the originally described H-ABC patients, for whom we provide follow-up 11 years after the original publication. The second novel mutation, p.R262H, was found in a patient with a typical clinical presentation for H-ABC"
Preserves both additional H-ABC alleles without assigning them the functional results measured for p.Arg2Trp or p.Asp249Asn.
PMID:23595291 SUPPORT Human Clinical
"Genome sequencing revealed a missense variant in the TUBB4 (tubulin beta-4; Arg2Gly) gene as the likely cause of disease."
Establishes the familial p.Arg2Gly DYT allele.
💊

Medical Actions

8
Medical Management of Dystonia
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Individualized medical management for dystonia. GeneReviews does not name a specific agent, so none is inferred here. This symptomatic record is kept separate from deep brain stimulation.
Target Phenotypes: Dystonia HP:0001332 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Dystonia (HP:0001332). HP:0001332 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"Dystonia requires medical management and, when refractory to medical management, possibly surgical intervention."
Supports medical management while leaving specific drug choice unstated.
Bipallidal Deep Brain Stimulation for Refractory DYT-TUBB4A
Action: Deep Brain StimulationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Deep Brain Stimulation (NCIT:C21024). NCIT:C21024 is a clinical intervention from the NCI Thesaurus. NCIT:C21024
Bilateral pallidal deep brain stimulation reduced dystonia severity by 55% at six months in one 44-year-old patient with DYT-TUBB4A. This is a single case report, not evidence of general efficacy and not an H-ABC treatment.
Target Phenotypes: Dystonia HP:0001332 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Dystonia (HP:0001332). HP:0001332 is a phenotype from the Human Phenotype Ontology. Laryngeal dystonia HP:0012049 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Laryngeal dystonia (HP:0012049). HP:0012049 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33084096 SUPPORT Human Clinical
"Bipallidal deep brain stimulation (DBS) resulted in a 55% reduction of dystonia severity assessed by the Burke-Fahn-Marsden scale score 6 months after surgery."
Reports the case-level outcome; the single-patient design is retained in the treatment description and context.
Adaptive Equipment and Physical Therapy for Spasticity
Action: physical therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is physical therapy (NCIT:C15302). NCIT:C15302 is a clinical intervention from the NCI Thesaurus. Ontology label: Physical Therapy NCIT:C15302
Adaptive equipment such as wheelchairs and walkers plus physical therapy for functionally disabling spasticity, with prevention of secondary injury as the stated aim.
Target Phenotypes: Spasticity HP:0001257 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Spasticity (HP:0001257). HP:0001257 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"Functionally disabling spasticity may require adaptive equipment (e.g., wheelchairs and walkers) and physical therapy to help prevent secondary injury."
States the supportive management of the motor phenotype.
Speech Therapy and Augmentative Communication
Action: speech and language therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is speech and language therapy, annotated with Speech Language Therapy (NCIT:C159273). NCIT:C159273 is a clinical intervention from the NCI Thesaurus. Ontology label: Speech Language Therapy NCIT:C159273
Speech therapy with augmentative and alternative communication for dysarthria and dysphonia when speech becomes insufficient.
Target Phenotypes: Dysarthria HP:0001260 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Dysarthria (HP:0001260). HP:0001260 is a phenotype from the Human Phenotype Ontology. Dysphonia HP:0001618 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Dysphonia (HP:0001618). HP:0001618 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"Dysarthria and dysphonia require speech therapy and possible augmentative and alternative communication."
Supports both the therapy and communication escalation.
Gastrostomy Feeding for Swallowing Dysfunction
Action: gastrostomyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is gastrostomy (NCIT:C52006). NCIT:C52006 is a clinical intervention from the NCI Thesaurus. Ontology label: Gastrostomy NCIT:C52006
Gastrostomy tube placement may be required when progressive swallowing dysfunction prevents safe oral feeding.
Target Phenotypes: Dysphagia HP:0002015 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Dysphagia (HP:0002015). HP:0002015 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"Swallowing dysfunction may require gastrostomy tube placement for feeding."
Supports gastrostomy for the swallowing phenotype.
Multidisciplinary Surveillance
Action: Supportive CareNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Supportive Care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. NCIT:C15747
Routine swallowing and feeding evaluation, nutritional support, orthopaedic assessment, and annual neurologic and cardiac review address complications of pediatric TUBB4A disease without modifying the causal mechanism.
Show evidence (2 references)
PMID:27809427 SUPPORT Other
"Surveillance: Routine evaluations of swallowing and feeding to reduce the risk of aspiration; nutritional support to prevent malnutrition; orthopedic assessment to detect musculoskeletal issues including joint dislocations and scoliosis."
Supports the feeding, nutrition, and orthopaedic surveillance schedule.
PMID:27809427 SUPPORT Other
"Annual neurologic assessment as well as cardiac evaluation to identify related complications."
Supports the annual neurologic and cardiac components.
Levodopa-Carbidopa and Trihexyphenidyl (Single-Patient Nonresponse)
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
One H-ABC patient received levodopa/carbidopa and trihexyphenidyl without benefit. This narrowly records a case-level negative observation and does not establish class ineffectiveness or a treatment recommendation.
Target Phenotypes: Dystonia HP:0001332 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Dystonia (HP:0001332). HP:0001332 is a phenotype from the Human Phenotype Ontology. Rigidity HP:0002063 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Rigidity (HP:0002063). HP:0002063 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24706558 REFUTE Human Clinical
"He was treated with levodopa/carbidopa and trihexyphenidyl without benefit, and is currently on baclofen for his increased muscle tone, with questionable effect."
A single-patient nonresponse, explicitly not generalized to either drug class or the broader spectrum.
Tubb4a-suppressing antisense oligonucleotide (preclinical)
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
An H-ABC-specific preclinical strategy. The rationale comes from an allelic mouse series showing that disease severity correlates with mutant Tubb4a expression and with relative preservation of wild-type tubulin - so lowering the mutant transcript should help even without repairing it. A single intracerebroventricular dose of a Tubb4a-targeted ASO in postnatal Tubb4a D249N/KO mice drastically extended lifespan, improved motor phenotypes, reduced seizures, prevented myelin and oligodendrocyte loss, and recovered visual evoked potential latencies. A stated limitation is that the ASO fails to reach cerebellar granule neurons by any tested route, so the cerebellar arm of the disease may be untreated by this approach. There is no human trial; this must not be curated as an available therapy or extrapolated to DYT-TUBB4A.
Mechanism Target:
INHIBITS H-ABC Antimorphic Microtubule Dysfunction — Reducing Tubb4a transcript lowers the D249N mutant-subunit burden modeled at the H-ABC-specific trigger node.
Show evidence (1 reference)
PMID:41566774 SUPPORT Model Organism
"we identified a well-tolerated Tubb4a-targeted antisense oligonucleotide (ASO) candidate that selectively reduces Tubb4a"
Establishes the agent and its mechanism of action on this node - selective reduction of the Tubb4a transcript.
Show evidence (2 references)
PMID:41566774 SUPPORT Model Organism
"Notably, single intracerebroventricular administration of ASO in postnatal Tubb4aD249N/KO mice drastically extends its lifespan, improves motor phenotypes, and reduces seizures."
Reports the efficacy readouts of the preclinical proof of concept.
PMID:41566774 SUPPORT Model Organism
"A major limitation we noted is that ASOs fail to target cerebellar granule neurons even with multiple routes of administration in the brain."
The authors' own stated limitation, recorded so the cerebellar gap is not lost when this strategy is cited.
🔬

Diagnosis

2
Brain magnetic resonance imaging
MRI can identify hypomyelination and, in H-ABC, caudate, putaminal, or cerebellar atrophy. These findings raise suspicion but are not obligatory: an H-ABC p.Arg262His case lacked caudate and putaminal atrophy after seven years, and DYT-TUBB4A can have normal imaging. Molecular testing establishes the diagnosis.
magnetic resonance imaging NCIT:C16809 NCI Thesaurus (NCIT)
Show evidence (2 references)
PMID:27809427 SUPPORT Other
"The diagnosis is established in a proband with characteristic clinical and/or brain MRI findings and a heterozygous TUBB4A pathogenic variant identified by molecular genetic testing."
Names MRI as part of the established diagnostic criterion.
PMID:24706558 SUPPORT Human Clinical
"Thus mutations in this gene should be suspected in any patient with hypomyelination, regardless of the long-term presence of neostriatal atrophy."
Prevents neostriatal atrophy from being represented as a required imaging criterion.
Molecular genetic testing
Diagnosis is confirmed by a heterozygous pathogenic TUBB4A variant on molecular genetic testing.
genetic testing NCIT:C15709 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"a heterozygous TUBB4A pathogenic variant identified by molecular genetic testing"
Names molecular testing as the confirmatory step.
📈

Progression

2
Onset, spanning infancy to adulthood
Age: Infancy to adulthood
Onset age is the primary axis of the spectrum: early-infantile gives hypomyelination with developmental stagnation, encephalopathy, seizures and hypotonia; late-infantile gives acquisition then regression with dystonia; juvenile or adult onset gives milder disease including isolated dystonia.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"TUBB4A-related neurologic disorders comprise a phenotypic spectrum ranging in onset from infancy to adulthood."
States the onset range that structures the whole spectrum.
Progressive multi-system neurologic decline
Age: Variable, following onset
Pyramidal, extrapyramidal, cerebellar and bulbar systems become progressively involved. Rate of progression varies with disease severity. Cognition is variably affected and usually less severely than motor function - a point that matters for goal-setting, since communication and comprehension may substantially outrun motor capacity.
Show evidence (1 reference)
PMID:27809427 SUPPORT Other
"Cognition is variably affected and is usually less severely affected than motor function. The rate of progression varies with disease severity."
States both the cognitive-motor dissociation and the severity-dependent rate of progression.
⚖️

Clinical Burden

High
High in pediatric-onset TUBB4A leukodystrophy. The infantile forms involve loss of ambulation, refractory dystonia, dysarthria and dysphonia requiring speech therapy and often gastrostomy, and lifelong dependence on adaptive equipment and multidisciplinary care. Surveillance requirements are substantial: swallowing and feeding evaluation to reduce aspiration risk, nutritional support, orthopaedic assessment for joint dislocation and scoliosis, and annual neurologic and cardiac review. The 58-caregiver burden study applies to pediatric-onset leukodystrophy and is not generalized to DYT-TUBB4A, whose burden profile can be materially different.
Show evidence (2 references)
PMID:27809427 SUPPORT Other
"Routine evaluations of swallowing and feeding to reduce the risk of aspiration; nutritional support to prevent malnutrition; orthopedic assessment to detect musculoskeletal issues including joint dislocations and scoliosis."
The surveillance schedule is a direct measure of the ongoing care burden.
PMID:41129987 SUPPORT Human Clinical
"Overall, 58 caregivers participated in the study. The VABS-3 (n = 58) demonstrated a lesser impact on the Communication and Socialization Domains compared to Activities of Daily Living and Motor Domains"
Quantifies the pediatric-leukodystrophy functional burden; it is explicitly not evidence for the DYT-TUBB4A subtype.
🐁

Animal Models

2
Tubb4a D249N allelic mouse series
An H-ABC p.Asp249Asn graded allelic series that establishes the dose relationship underpinning the therapeutic strategy: severity correlates with mutant Tubb4a expression and with relative preservation of wild-type tubulin. The D249N/KO animals provide the treatment substrate for the ASO experiment. It is not a model of DYT-TUBB4A.
Species
Mouse
Genotype
Tubb4a KO/KO, D249N/+, D249N/KO and D249N/D249N
Publication
PMID:41566774
Pathograph links
H-ABC Antimorphic Microtubule Dysfunction recapitulates fidelity: moderate Models the recurrent human H-ABC allele, and the allelic series isolates the mutant-to-wild-type ratio as the severity determinant.
Limitations: Severe phenotypes principally occur in D249N/D249N or D249N/null animals; the treated D249N/null genotype has no direct human equivalent. Mouse myelination timing and lifespan also differ from human, so the model is informative but not high fidelity.
Readouts
Disease severity versus mutant Tubb4a expression
Direction: ALTERED
Interpretation: Severity scales with mutant expression and inversely with preserved wild-type tubulin.
Show evidence (1 reference)
PMID:41566774 SUPPORT Model Organism
"we characterized a genetic murine series (Tubb4aKO/KO, Tubb4aD249N/+, Tubb4aD249N/KO, and Tubb4aD249N/D249N) to demonstrate that disease severity correlates with the expression of mutant Tubb4a and relative preservation of wild-type tubulin."
Reports the dose-severity relationship measured across the series.
Show evidence (1 reference)
PMID:41566774 SUPPORT Model Organism
"This is the first preclinical proof-of-concept for Tubb4a suppression via ASO as a disease-modifying therapy for H-ABC."
The model is the basis of the only disease-modifying strategy reported for this disorder.
Oligodendrocyte Dysfunction and Myelin Failure rescues fidelity: moderate ASO treatment prevents myelin and oligodendrocyte loss and preserves Mbp mRNA transport, demonstrating the myelin arm is reversible in the model if the mutant burden is lowered early.
Limitations: Rescue is postnatal in a mouse whose myelination is largely postnatal; the equivalent human window is not established. Cerebellar granule neurons are not reached by the ASO.
Readouts
Myelin and oligodendrocyte preservation under ASO
myelination GO:0042552 Gene Ontology (GO) Relation: this readout reports on this biological process This readout reports on decreased myelination (GO:0042552). GO:0042552 is a biological process from the Gene Ontology. ↓ DECREASED
Direction: RESTORED
Interpretation: Treatment prevents the myelin and oligodendrocyte loss that otherwise occurs.
Show evidence (1 reference)
PMID:41566774 SUPPORT Model Organism
"Neuropathologically, treating ASO Tubb4aD249N/KO mice prevents myelin and oligodendrocyte (OL) loss and recovers visual evoked potential latencies in vivo."
Reports the neuropathological and electrophysiological rescue.
Show evidence (1 reference)
PMID:41566774 SUPPORT Model Organism
"Furthermore, the microtubule function of Mbp mRNA transport from the OL soma to the myelin sheath is retained."
Links the rescue back to the specific microtubule-dependent function this node curates.
Tubb4a H-ABC mutant mouse (glial and neuronal degeneration)
An H-ABC-specific homozygous D249N model that degenerates both glia and neurons, providing evidence for curating the myelin and neurodegeneration arms as parallel branches rather than treating grey-matter atrophy as secondary to myelin failure. It does not model DYT-TUBB4A.
Species
Mouse
Genotype
Tubb4a D249N/D249N
Publication
PMID:32463361
Pathograph links
Basal Ganglia and Cerebellar Neurodegeneration recapitulates fidelity: moderate Reproduces neuronal degeneration alongside the glial phenotype.
Limitations: The prominent phenotype is in homozygous D249N animals rather than the heterozygous human state. Regional correspondence and causal ordering of glial versus neuronal pathology therefore remain incomplete.
Show evidence (1 reference)
PMID:32463361 SUPPORT Model Organism
"Additionally, a significant loss occurs in the cerebellar granular neurons and striatal neurons in Tubb4aD249N/D249N mice."
Reports measured neuronal loss in striatum and cerebellar granule layer in the knock-in model.
{ }

Source YAML

click to show 
name: TUBB4A-related Neurologic Disorder
creation_date: "2026-08-20T16:00:00Z"
category: Mendelian
disease_term:
  preferred_term: TUBB4A-related neurologic disorder
  term:
    id: MONDO:0800470
    label: TUBB4A-related neurologic disorder
description: >-
  TUBB4A-related neurologic disorder is an autosomal dominant allelic spectrum
  that spans pediatric-onset hypomyelinating and neurodegenerative disease and
  juvenile- or adult-onset dystonia. Hypomyelination with atrophy of the basal
  ganglia and cerebellum (H-ABC; hypomyelinating leukodystrophy 6) is an
  ontology-grounded subtype of this spectrum, not a synonym for the umbrella
  disorder. Its white-matter and grey-matter abnormalities are parallel features:
  hypomyelination may be diffuse or mild and focal, while caudate and putaminal
  atrophy can be absent even after years of follow-up. DYT-TUBB4A (historically
  DYT4 or whispering dysphonia) is a distinct, usually inherited movement-disorder
  presentation with prominent laryngeal and generalized dystonia and typically
  normal neuroimaging.

  The molecular effects are allele specific. The studied H-ABC p.Arg2Trp and
  p.Asp249Asn substitutions have antimorphic effects on microtubule assembly,
  whereas the DYT-associated p.Arg2Gly substitution produced neuronal morphology
  changes without a prominent microtubule-dynamics defect and p.Gln424His showed
  increased growth dynamics consistent with gain of function. The p.Cys239Phe and
  p.Arg262His H-ABC alleles expand the clinical and imaging spectrum but have not
  been assigned those tested functional mechanisms. This heterogeneity is why no
  single functional-impact category or variant origin is asserted for the
  umbrella disorder.
parents:
- hereditary neurological disease
- movement disorder
references:
- reference: PMID:27809427
  title: TUBB4A-Related Neurologic Disorders.
  tags:
  - GeneReviews
- reference: PMID:35275727
  title: H-ABC- and dystonia-causing TUBB4A mutations show distinct pathogenic effects.
- reference: PMID:24706558
  title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
- reference: PMID:28973395
  title: TUBB4A mutations result in specific neuronal and oligodendrocytic defects that closely match clinically distinct phenotypes.
- reference: PMID:23595291
  title: Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene.
- reference: PMID:33084096
  title: Whispering dysphonia in TUBB4A-related disorders responsive to bipallidal deep brain stimulation.
- reference: PMID:41566774
  title: Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophy.
- reference: PMID:32463361
  title: TUBB4A mutations result in both glial and neuronal degeneration in an H-ABC leukodystrophy mouse model.
- reference: PMID:42044700
  title: H-ABC tubulinopathy exhibits a cytoskeletal defect associated with microtubule stability.
- reference: PMID:41129987
  title: "Critical Functional Domains in Pediatric Onset TUBB4A-Related Leukodystrophy: A Clinical and Caregiver's Perspective."
inheritance:
- name: Autosomal dominant inheritance
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  description: >-
    A heterozygous pathogenic TUBB4A variant is sufficient across the spectrum,
    but origin differs by subtype. H-ABC is usually simplex and de novo; parental
    somatic mosaicism has been documented, so recurrence risk is not zero after
    negative parental blood testing. DYT-TUBB4A is usually inherited and was
    mapped in a multigenerational family. An affected individual has a 50% chance
    of transmitting the variant to each child.
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      TUBB4A-related neurologic disorders are inherited in an autosomal dominant
      manner.
    explanation: >-
      GeneReviews states the inheritance mode for the whole phenotypic spectrum.
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Each child of an individual with a TUBB4A-related neurologic disorder has
      a 50% chance of inheriting the TUBB4A pathogenic variant.
    explanation: >-
      GeneReviews directly supports the 50% transmission risk for a child of an
      affected heterozygous individual. This is distinct from the recurrence
      risk after an apparently de novo variant or parental mosaicism.
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The diagnosis is established in a proband with characteristic clinical
      and/or brain MRI findings and a heterozygous TUBB4A pathogenic variant
      identified by molecular genetic testing.
    explanation: >-
      Confirms that a single heterozygous variant is sufficient for diagnosis.
  - reference: PMID:24706558
    reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All 11 patients described in that publication had the same heterozygous
      c.745G>A (p.D249N) mutation, which was a de novo change in all patients
      studied, except in one family where somatic mosaicism was detected in the
      clinically unaffected mother.
    explanation: >-
      Documents both the usual de novo H-ABC origin and the parental-mosaicism
      exception; this evidence is not generalized to DYT-TUBB4A.
  - reference: PMID:23595291
    reference_title: Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A study was undertaken to identify the gene underlying DYT4 dystonia, a
      dominantly inherited form of spasmodic dysphonia combined with other focal
      or generalized dystonia and a characteristic facies and body habitus, in an
      Australian family.
    explanation: >-
      Establishes the inherited familial pattern at the DYT-TUBB4A pole.
pathophysiology:
- name: Altered Beta-Tubulin 4A (TUBB4A) Function
  role: TRIGGER
  biological_scale: MOLECULAR
  description: >-
    Heterozygous missense variants alter the brain-enriched beta-tubulin 4A
    isotype, but this locus-level trigger does not imply one downstream mechanism.
    H-ABC and DYT-associated alleles have divergent cellular effects, so the
    graph immediately separates an H-ABC oligodendrocyte/grey-matter branch from
    a cautious DYT neuronal branch.
  genetic_context:
    functional_impact_category: UNKNOWN
    zygosity: HETEROZYGOUS
    allele_type: missense
    description: >-
      UNKNOWN is deliberate at the umbrella level. p.Arg2Trp and p.Asp249Asn were
      interpreted as antimorphic, p.Gln424His showed a gain-of-function growth
      pattern, and p.Arg2Gly showed no prominent dynamics change. p.Cys239Phe and
      p.Arg262His are established H-ABC alleles without equivalent functional
      testing in the cached evidence. Variant origin is omitted because H-ABC is
      usually de novo whereas DYT-TUBB4A is often inherited.
  genes:
  - preferred_term: TUBB4A
    term:
      id: hgnc:20774
      label: TUBB4A
  evidence:
  - reference: PMID:35275727
    reference_title: H-ABC- and dystonia-causing TUBB4A mutations show distinct pathogenic effects.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Using live-cell imaging of disease-relevant oligodendrocytes and total
      internal reflection fluorescence microscopy of whole-cell lysates, we
      observed divergent impact on microtubule polymerization and microtubule
      integration, partially reflecting the observed pleiotropy.
    explanation: >-
      Establishes both the molecular lesion (perturbed polymerization and
      incorporation) and its non-uniformity across disease-causing alleles.
  - reference: PMID:35275727
    reference_title: H-ABC- and dystonia-causing TUBB4A mutations show distinct pathogenic effects.
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: >-
      Moreover, in silico simulations demonstrated that the mutants rarely adopted
      a straight heterodimer conformation in contrast to wild type.
    explanation: >-
      Structural evidence for allele-specific conformational effects; it is not
      used to assign one functional-impact category across the spectrum.
  downstream:
  - target: H-ABC Antimorphic Microtubule Dysfunction
    causal_link_type: DIRECT
    description: >-
      The studied p.Arg2Trp and p.Asp249Asn H-ABC alleles reduce incorporation and
      microtubule growth and were interpreted as antimorphic.
  - target: DYT-TUBB4A-Associated Neuronal Dysfunction
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      DYT alleles act through a distinct neuronal route, but p.Arg2Gly and
      p.Gln424His do not share one experimentally established molecular effect.
- name: H-ABC Antimorphic Microtubule Dysfunction
  role: TRIGGER
  biological_scale: MOLECULAR
  subtypes:
  - H-ABC
  conforms_to: "cns_myelin_failure#Oligodendrocyte-Lineage or Myelin-Membrane Insult"
  description: >-
    In the studied H-ABC alleles p.Arg2Trp and p.Asp249Asn, mutant heterodimers
    incorporate less efficiently, grow more slowly, and can act as steric blocks
    during assembly. This antimorphic mechanism is limited to those tested
    alleles; it is not assigned to p.Cys239Phe or p.Arg262His merely because they
    also cause H-ABC.
  genetic_context:
    functional_impact_category: DOMINANT_NEGATIVE
    zygosity: HETEROZYGOUS
    allele_type: missense
    description: >-
      Applies to the experimentally studied H-ABC p.Arg2Trp and p.Asp249Asn
      substitutions. The functional category records their reported antimorphic
      behavior and is not a spectrum-wide assertion.
  genes:
  - preferred_term: TUBB4A
    term:
      id: hgnc:20774
      label: TUBB4A
  evidence:
  - reference: PMID:35275727
    reference_title: H-ABC- and dystonia-causing TUBB4A mutations show distinct pathogenic effects.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Therefore, we suggest an antimorphic conformational change in the H-ABC
      mutants, but not to a complete loss of function of the affected tubulin
      heterodimers. Hence, the H-ABC mutants might act as steric hindrances during
      microtubule assembly.
    explanation: >-
      Supplies the antimorphic interpretation for the tested H-ABC variants.
  - reference: PMID:35275727
    reference_title: H-ABC- and dystonia-causing TUBB4A mutations show distinct pathogenic effects.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      On the other side of the phenotypic spectrum, the H-ABC-causing mutations
      p.R2W and p.D249N showed significantly reduced growth dynamics.
    explanation: >-
      Directly identifies the two H-ABC alleles to which the reduced-growth claim
      applies.
  downstream:
  - target: Oligodendrocyte Dysfunction and Myelin Failure
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - impaired microtubule assembly and oligodendrocyte process formation
    description: >-
      Severe microtubule-dynamics disruption impairs oligodendrocyte maturation
      and myelin production.
  - target: Basal Ganglia and Cerebellar Neurodegeneration
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      H-ABC also has a parallel neuronal/grey-matter arm, but its route from the
      allele-specific tubulin defect is not resolved.
- name: DYT-TUBB4A-Associated Neuronal Dysfunction
  biological_scale: CELLULAR
  subtypes:
  - DYT-TUBB4A
  description: >-
    The DYT-associated p.Arg2Gly allele altered neuronal morphology while leaving
    tubulin quantity, polymerization, oligodendrocyte morphology, and myelin-gene
    expression unchanged in the reported cellular study. p.Gln424His instead
    increased microtubule growth dynamics, consistent with gain of function.
    These allele-specific observations support a neuronal branch independent of
    H-ABC myelin failure, but do not yet establish a single intervening pathway.
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  evidence:
  - reference: PMID:28973395
    reference_title: TUBB4A mutations result in specific neuronal and oligodendrocytic defects that closely match clinically distinct phenotypes.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Thus, the DYT4 mutation that leads to phenotypes attributable to neuronal
      dysfunction results in altered neuronal morphology, but with unchanged
      tubulin quantity and polymerization, with normal oligodendrocyte morphology
      and myelin gene expression.
    explanation: >-
      Supports a neuronal, non-myelin route for p.Arg2Gly without asserting a
      microtubule-dynamics defect.
  - reference: PMID:35275727
    reference_title: H-ABC- and dystonia-causing TUBB4A mutations show distinct pathogenic effects.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      When compared to WT TUBB4A, the dystonia-associated mutants showed either
      no differences (p.R2G) or considerably increased growth dynamics (p.Q424H).
    explanation: >-
      Preserves the different functional results for the two tested DYT alleles.
  downstream:
  - target: Dystonia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The neuronal defect is associated with generalized dystonia.
  - target: Laryngeal Dystonia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Laryngeal involvement produces the characteristic whispering dysphonia.
  - target: Dysphonia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Voice impairment is a cardinal manifestation of DYT-TUBB4A.
- name: Oligodendrocyte Dysfunction and Myelin Failure
  subtypes:
  - H-ABC
  conforms_to: "cns_myelin_failure#Oligodendrocyte Differentiation Arrest and Death"
  biological_scale: CELLULAR
  description: >-
    In H-ABC, oligodendrocyte differentiation, process formation, and myelin
    production are impaired. The D249N allelic mouse series identifies Mbp mRNA
    transport from the oligodendrocyte soma to the sheath as one vulnerable
    microtubule-dependent function. The A302T taiep rat instead shows increased
    tubulin post-translational modifications associated with stability, warning
    that the direction of microtubule disturbance and the neuronal contribution
    are allele- and model-specific rather than universal.
  cell_types:
  - preferred_term: oligodendrocyte
    term:
      id: CL:0000128
      label: oligodendrocyte
  biological_processes:
  - preferred_term: myelination
    term:
      id: GO:0042552
      label: myelination
    modifier: DECREASED
  - preferred_term: microtubule-based transport
    term:
      id: GO:0099111
      label: microtubule-based transport
    modifier: DECREASED
  locations:
  - preferred_term: cerebral white matter
    term:
      id: UBERON:0002316
      label: white matter
  evidence:
  - reference: PMID:41566774
    reference_title: Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophy.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Furthermore, the microtubule function of Mbp mRNA transport from the OL
      soma to the myelin sheath is retained.
    explanation: >-
      Identifies the specific microtubule-dependent oligodendrocyte function at
      stake - Mbp mRNA transport to the sheath - by showing it is preserved when
      the mutant transcript is suppressed.
  - reference: PMID:42044700
    reference_title: H-ABC tubulinopathy exhibits a cytoskeletal defect associated with microtubule stability.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Compared to controls, taiep rats displayed significantly elevated levels
      of tubulin acetylation and detyrosination within white matter regions.
    explanation: >-
      Animal-model evidence for an oligodendrocyte cytoskeletal defect associated
      with microtubule stability; it is not classified as an in-vitro result.
  downstream:
  - target: CNS Hypomyelination
    causal_link_type: DIRECT
    description: >-
      Failure of oligodendrocyte myelin production produces the hypomyelination
      seen on MRI.
  - target: Progressive Motor and Bulbar Decline
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - deficient CNS myelin and impaired long-tract conduction
    description: >-
      Loss of myelinated-tract function contributes to the H-ABC motor decline,
      alongside the parallel grey-matter arm.
- name: Basal Ganglia and Cerebellar Neurodegeneration
  subtypes:
  - H-ABC
  biological_scale: TISSUE
  description: >-
    H-ABC has a grey-matter arm parallel to hypomyelination. The common pattern
    includes progressive caudate, putaminal, and cerebellar atrophy, but it is not
    obligatory: a p.Arg262His patient retained stable caudate and putaminal size
    over seven years, and mild thalamic atrophy occurred in other followed
    patients. The D249N mouse shows striatal and cerebellar granule-neuron loss.
    This node is H-ABC-specific and is not used to explain DYT-TUBB4A, which can
    have normal neuroimaging.
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  locations:
  - preferred_term: basal ganglia
    term:
      id: UBERON:0002420
      label: basal ganglion
  - preferred_term: cerebellum
    term:
      id: UBERON:0002037
      label: cerebellum
  evidence:
  - reference: PMID:32463361
    reference_title: TUBB4A mutations result in both glial and neuronal degeneration in an H-ABC leukodystrophy mouse model.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Additionally, a significant loss occurs in the cerebellar granular
      neurons and striatal neurons in Tubb4aD249N/D249N mice.
    explanation: >-
      Reports measured loss of cerebellar granule and striatal neurons, the
      neuronal arm of this node.
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      A subset of individuals with late-infantile onset progress to
      hypomyelination with atrophy of the basal ganglia and cerebellum.
    explanation: >-
      Documents the structural atrophy of basal ganglia and cerebellum that
      occurs in a subset of the spectrum.
  - reference: PMID:24706558
    reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The second novel mutation, p.R262H, was found in a patient with a typical
      clinical presentation for H-ABC, but with a novel neuroimaging phenotype,
      given the absence of atrophy of the putamen and caudate nucleus despite 7
      years of follow-up.
    explanation: >-
      Directly prevents the common atrophy pattern from being modeled as
      obligatory or diagnostic.
  downstream:
  - target: Dystonia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Striatal pathology plausibly contributes to H-ABC dystonia, but the
      patient-level route is not demonstrated.
  - target: Ataxia
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - cerebellar neuronal loss and circuit dysfunction
    description: Cerebellar degeneration produces ataxia, intention tremor and dysmetria.
  - target: Cerebellar Atrophy
    causal_link_type: DIRECT
    description: The structural correlate of the cerebellar arm.
  - target: Abnormal Basal Ganglia Morphology
    causal_link_type: DIRECT
    description: >-
      The structural correlate of the caudate and putaminal arm, with documented
      exceptions and no claim of universal thalamic sparing.
  - target: Progressive Motor and Bulbar Decline
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - striatal and cerebellar circuit dysfunction
    description: >-
      Extrapyramidal and cerebellar degeneration contribute to the progressive
      decline in motor and bulbar function.
- name: CNS Hypomyelination
  subtypes:
  - H-ABC
  conforms_to: "cns_myelin_failure#Deficient or Unstable CNS Myelin Sheath"
  biological_scale: TISSUE
  description: >-
    Deficient CNS myelin is characteristic of H-ABC and other pediatric TUBB4A
    presentations, but severity varies. In the three longitudinally imaged H-ABC
    patients in PMID:24706558 it was generalized in two and focal and milder in
    one. That three-patient observation is not converted into an obligatory
    frequency claim for H-ABC or the umbrella disorder.
  locations:
  - preferred_term: cerebral white matter
    term:
      id: UBERON:0002316
      label: white matter
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Brain imaging at the time of developmental loss typically identifies
      hypomyelination.
    explanation: >-
      Establishes hypomyelination as the characteristic imaging finding at the
      point of clinical decline.
  - reference: PMID:24706558
    reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Hypomyelination was found in all patients and was generalized in Patients 1
      (Fig. 1B,D) and 2 (Fig. 1F,H), but focal and milder in Patient 3.
    explanation: >-
      Establishes variable extent in the three longitudinally studied patients;
      it does not establish a population-wide obligatory frequency.
  downstream:
  - target: CNS Hypomyelination Phenotype
    causal_link_type: DIRECT
    description: The MRI-defined phenotype itself.
- name: Progressive Motor and Bulbar Decline
  subtypes:
  - H-ABC
  biological_scale: ORGANISM
  description: >-
    The H-ABC clinical endpoint combines four systems:
    pyramidal tracts (spasticity, brisk reflexes, Babinski), extrapyramidal
    system (rigidity, dystonia, choreoathetosis, oculogyric crisis, perioral
    dyskinesia), cerebellum (ataxia, intention tremor, dysmetria) and bulbar
    function (dysarthria, dysphonia, swallowing). It intentionally does not
    conform to the white-matter module because the grey- and white-matter arms
    both contribute.
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Progressive neurologic findings reflect involvement of the pyramidal tracts
      (spasticity, brisk deep tendon reflexes, and Babinski sign), extrapyramidal
      system (rigidity, dystonia, choreoathetosis, oculogyric crisis, and perioral
      dyskinesia), cerebellum (ataxia, intention tremor, dysmetria), and bulbar
      function (dysarthria, dysphonia, and swallowing).
    explanation: >-
      Enumerates the four systems whose progressive involvement constitutes the
      clinical decline.
  downstream:
  - target: Spasticity
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - pyramidal tract dysfunction
    description: Pyramidal tract involvement.
  - target: Dysarthria
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - bulbar and cerebellar motor dysfunction
    description: Bulbar involvement.
  - target: Dysphonia
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - bulbar motor dysfunction
    description: Voice impairment from bulbar involvement in H-ABC.
  - target: Dysphagia
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - bulbar swallowing dysfunction
    description: Progressive bulbar involvement impairs swallowing.
  - target: Rigidity
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - extrapyramidal circuit dysfunction
    description: Extrapyramidal involvement produces rigidity.
  - target: Choreoathetosis
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - extrapyramidal circuit dysfunction
    description: Extrapyramidal involvement produces choreoathetosis.
  - target: Intention Tremor
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - cerebellar circuit dysfunction
    description: Cerebellar involvement produces intention tremor.
  - target: Dysmetria
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - cerebellar circuit dysfunction
    description: Cerebellar involvement produces dysmetria.
  - target: Developmental Regression
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Loss of previously acquired milestones is the presenting event in the
      late-infantile form.
  - target: Loss of Ambulation
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - progressive pyramidal, extrapyramidal, and cerebellar dysfunction
    description: Motor decline typically costs independent walking.
  - target: Hypotonia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Hypotonia occurs in severe pediatric presentations.
  - target: Seizures
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Seizures occur in a minority of H-ABC patients.
  - target: Nystagmus
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The route to the oculomotor finding is not established.
  - target: Sensorineural Hearing Impairment
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The route to hearing impairment is not established.
has_subtypes:
- name: H-ABC
  display_name: Hypomyelination with atrophy of the basal ganglia and cerebellum (HLD6)
  classification: clinical_phenotype
  subtype_term:
    preferred_term: leukodystrophy, hypomyelinating, 6
    term:
      id: MONDO:0012905
      label: "leukodystrophy, hypomyelinating, 6"
  description: >-
    The ontology-grounded H-ABC/HLD6 subtype, typically pediatric onset with
    progressive pyramidal, extrapyramidal, cerebellar, and bulbar dysfunction.
    Hypomyelination and caudate, putaminal, or cerebellar atrophy are important
    imaging features but are variable over time and by allele; p.Arg262His was
    associated with typical clinical H-ABC without caudate or putaminal atrophy
    after seven years. MONDO:0012905 is retained only here and does not make the
    umbrella disorder synonymous with a leukodystrophy.
  genes:
  - preferred_term: TUBB4A
    term:
      id: hgnc:20774
      label: TUBB4A
  evidence:
  - reference: PMID:41566774
    reference_title: Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The recurring variant p.Asp249Asn (D249N) presents in infancy with
      dystonia, communication deficits, and loss of ambulation during the first
      decade of life.
    explanation: >-
      Characterizes the recurrent H-ABC allele and its clinical course.
  - reference: PMID:24706558
    reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The second novel mutation, p.R262H, was found in a patient with a typical
      clinical presentation for H-ABC, but with a novel neuroimaging phenotype,
      given the absence of atrophy of the putamen and caudate nucleus despite 7
      years of follow-up.
    explanation: >-
      Establishes that the eponymous basal-ganglia atrophy is not obligatory.
- name: DYT-TUBB4A
  display_name: DYT-TUBB4A (DYT4 dystonia, whispering dysphonia)
  classification: clinical_phenotype
  description: >-
    Juvenile- or adult-onset dystonia, historically DYT4, commonly featuring
    laryngeal dystonia and whispering dysphonia. Familial inheritance is well
    documented, and neuroimaging can be normal. No subtype ontology term is
    assigned because none is available in the frozen local term cache.
  genes:
  - preferred_term: TUBB4A
    term:
      id: hgnc:20774
      label: TUBB4A
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Milder presentations are associated with juvenile or adult onset, including
      a typical adult-onset dystonia characterized as DYT-TUBB4A.
    explanation: >-
      Defines the mild adult-onset dystonia pole of the TUBB4A spectrum.
  - reference: PMID:23595291
    reference_title: Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A mutation in TUBB4 causes DYT4 dystonia in this Australian family with
      so-called whispering dysphonia, and other mutations in TUBB4 may contribute
      to spasmodic dysphonia.
    explanation: >-
      Provides the causal familial evidence and characteristic voice phenotype.
phenotypes:
- name: CNS Hypomyelination Phenotype
  description: >-
    Deficient CNS myelin on brain MRI. It is characteristic of pediatric
    hypomyelinating presentations but is not asserted as obligatory across H-ABC
    or the umbrella spectrum.
  phenotype_term:
    preferred_term: CNS hypomyelination
    term:
      id: HP:0003429
      label: CNS hypomyelination
  phenotype_contexts:
  - subtype: H-ABC
    notes: >-
      Hypomyelination occurred in all three longitudinal-study patients but
      ranged from generalized to focal and mild; this small selected series is
      not converted into a subtype-wide frequency.
    evidence:
    - reference: PMID:24706558
      reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Hypomyelination was found in all patients and was generalized in Patients 1
        (Fig. 1B,D) and 2 (Fig. 1F,H), but focal and milder in Patient 3.
      explanation: >-
        Supports H-ABC-specific occurrence and variable extent without an
        obligatory population-frequency claim.
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Brain imaging at the time of developmental loss typically identifies
      hypomyelination.
    explanation: Reports hypomyelination as the typical imaging finding.
- name: Dystonia
  subtypes:
  - H-ABC
  - DYT-TUBB4A
  description: >-
    The most characteristic movement finding, present across the spectrum - from
    the infantile H-ABC presentation to isolated adult-onset DYT-TUBB4A.
  phenotype_term:
    preferred_term: Dystonia
    term:
      id: HP:0001332
      label: Dystonia
    clinical_course: PROGRESSIVE
  phenotype_contexts:
  - subtype: H-ABC
    frequency: 88%
    notes: Exact reviewed H-ABC frequency, 88% of 30 published patients.
    evidence:
    - reference: PMID:24706558
      reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Spasticity was present in 100% of patients, while ataxia was present in
        87%, choreoathetosis in 45%, dystonia in 88%, rigidity in 69%, and
        dysarthria in 93%
      explanation: Records the exact H-ABC dystonia frequency without applying it to DYT.
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      extrapyramidal system (rigidity, dystonia, choreoathetosis, oculogyric
      crisis, and perioral dyskinesia)
    explanation: Lists dystonia among the extrapyramidal findings.
  - reference: PMID:41566774
    reference_title: Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The recurring variant p.Asp249Asn (D249N) presents in infancy with
      dystonia, communication deficits, and loss of ambulation during the first
      decade of life.
    explanation: Documents dystonia as a presenting feature of the recurrent H-ABC allele.
- name: Cerebellar Atrophy
  subtype: H-ABC
  description: >-
    Progressive cerebellar atrophy, often vermis-predominant, is an important
    H-ABC imaging feature but may emerge only on follow-up.
  phenotype_term:
    preferred_term: Cerebellar atrophy
    term:
      id: HP:0001272
      label: Cerebellar atrophy
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      A subset of individuals with late-infantile onset progress to
      hypomyelination with atrophy of the basal ganglia and cerebellum.
    explanation: Documents cerebellar atrophy as part of the H-ABC progression.
  - reference: PMID:24706558
    reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      At follow-up, we saw cerebellar atrophy in all patients
    explanation: >-
      Establishes the follow-up finding without turning a three-patient series
      into an obligatory subtype frequency.
- name: Ataxia
  description: Cerebellar ataxia with intention tremor and dysmetria.
  phenotype_term:
    preferred_term: Ataxia
    term:
      id: HP:0001251
      label: Ataxia
  phenotype_contexts:
  - subtype: H-ABC
    frequency: 87%
    notes: Exact reviewed H-ABC frequency, 87% of 30 published patients.
    evidence:
    - reference: PMID:24706558
      reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Spasticity was present in 100% of patients, while ataxia was present in
        87%, choreoathetosis in 45%, dystonia in 88%, rigidity in 69%, and
        dysarthria in 93%
      explanation: Records the exact H-ABC ataxia frequency.
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      cerebellum (ataxia, intention tremor, dysmetria)
    explanation: Lists ataxia among the cerebellar findings.
- name: Spasticity
  description: Pyramidal tract involvement with spasticity, brisk reflexes and Babinski sign.
  phenotype_term:
    preferred_term: Spasticity
    term:
      id: HP:0001257
      label: Spasticity
  phenotype_contexts:
  - subtype: H-ABC
    frequency: 100%
    notes: Exact reviewed H-ABC frequency, 100% of 30 published patients.
    evidence:
    - reference: PMID:24706558
      reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Spasticity was present in 100% of patients, while ataxia was present in
        87%, choreoathetosis in 45%, dystonia in 88%, rigidity in 69%, and
        dysarthria in 93%
      explanation: >-
        Records the exact H-ABC spasticity frequency on HP:0001257; the narrower
        lower-limb spasticity term is not used.
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      pyramidal tracts (spasticity, brisk deep tendon reflexes, and Babinski
      sign)
    explanation: Lists spasticity among the pyramidal findings.
- name: Dysarthria
  description: >-
    Bulbar and cerebellar impairment of articulation, distinct from dysphonia.
  phenotype_term:
    preferred_term: Dysarthria
    term:
      id: HP:0001260
      label: Dysarthria
  phenotype_contexts:
  - subtype: H-ABC
    frequency: 93%
    notes: Exact reviewed H-ABC frequency, 93% of 30 published patients.
    evidence:
    - reference: PMID:24706558
      reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Spasticity was present in 100% of patients, while ataxia was present in
        87%, choreoathetosis in 45%, dystonia in 88%, rigidity in 69%, and
        dysarthria in 93%
      explanation: Records the exact H-ABC dysarthria frequency.
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      bulbar function (dysarthria, dysphonia, and swallowing)
    explanation: Lists dysarthria and dysphonia among the bulbar findings.
- name: Developmental Regression
  description: >-
    The defining event of the late-infantile presentation: milestones including
    walking or supported ambulation are acquired and then lost.
  phenotype_term:
    preferred_term: Developmental regression
    term:
      id: HP:0002376
      label: Developmental regression
  phenotype_contexts:
  - subtype: H-ABC
    notes: >-
      H-ABC commonly follows an acquire-then-regress trajectory; no exact
      frequency is asserted from the available source.
    evidence:
    - reference: PMID:27809427
      reference_title: TUBB4A-Related Neurologic Disorders.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        A late-infantile presentation is often characterized by acquisition of
        developmental milestones including walking or supported ambulation with
        later onset of regression and dystonia.
      explanation: Supports the H-ABC developmental trajectory.
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      A late-infantile presentation is often characterized by acquisition of
      developmental milestones including walking or supported ambulation with
      later onset of regression and dystonia.
    explanation: Documents the acquire-then-lose trajectory that defines regression here.
- name: Loss of Ambulation
  description: >-
    Independent walking is typically lost, in the recurrent H-ABC allele during
    the first decade.
  phenotype_term:
    preferred_term: Loss of ambulation
    term:
      id: HP:0002505
      label: Loss of ambulation
  evidence:
  - reference: PMID:41566774
    reference_title: Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      presents in infancy with dystonia, communication deficits, and loss of
      ambulation during the first decade of life
    explanation: Reports loss of ambulation within the first decade for the recurrent allele.
- name: Hypotonia
  description: Axial hypotonia, characteristic of the severe early-infantile presentation.
  phenotype_term:
    preferred_term: Hypotonia
    term:
      id: HP:0001252
      label: Hypotonia
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      An early-infantile presentation is typically associated with
      hypomyelination, severe stagnation of developmental milestones,
      encephalopathy, seizures, and hypotonia.
    explanation: Lists hypotonia in the early-infantile presentation.
- name: Seizures
  description: Seizures occur in the severe early-infantile presentation.
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  phenotype_contexts:
  - subtype: H-ABC
    frequency: 18%
    notes: Exact reviewed H-ABC frequency, 18% of 30 published patients.
    evidence:
    - reference: PMID:24706558
      reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        nystagmus in 33%, decreased vision or poor visual tracking in 27%,
        sensorineural hearing loss in 14%, and seizures in 18%
      explanation: Records the exact H-ABC seizure frequency.
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      An early-infantile presentation is typically associated with
      hypomyelination, severe stagnation of developmental milestones,
      encephalopathy, seizures, and hypotonia.
    explanation: Lists seizures in the early-infantile presentation.
- name: Choreoathetosis
  subtype: H-ABC
  description: Choreoathetotic movements as part of the extrapyramidal H-ABC syndrome.
  phenotype_term:
    preferred_term: Choreoathetosis
    term:
      id: HP:0001266
      label: Choreoathetosis
  phenotype_contexts:
  - subtype: H-ABC
    frequency: 45%
    notes: Exact reviewed H-ABC frequency, 45% of 30 published patients.
    evidence:
    - reference: PMID:24706558
      reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Spasticity was present in 100% of patients, while ataxia was present in
        87%, choreoathetosis in 45%, dystonia in 88%, rigidity in 69%, and
        dysarthria in 93%
      explanation: Records the exact H-ABC frequency on the exact choreoathetosis term.
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      extrapyramidal system (rigidity, dystonia, choreoathetosis, oculogyric
      crisis, and perioral dyskinesia)
    explanation: Names choreoathetosis among the extrapyramidal manifestations.
- name: Nystagmus
  subtype: H-ABC
  description: Nystagmus, sometimes an early presenting oculomotor sign.
  phenotype_term:
    preferred_term: Nystagmus
    term:
      id: HP:0000639
      label: Nystagmus
  phenotype_contexts:
  - subtype: H-ABC
    frequency: 33%
    notes: Exact reviewed H-ABC frequency, 33% of 30 published patients.
    evidence:
    - reference: PMID:24706558
      reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        nystagmus in 33%, decreased vision or poor visual tracking in 27%,
        sensorineural hearing loss in 14%, and seizures in 18%
      explanation: Records the exact H-ABC nystagmus frequency.
  evidence:
  - reference: PMID:24706558
    reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      nystagmus in 33%, decreased vision or poor visual tracking in 27%,
      sensorineural hearing loss in 14%, and seizures in 18%
    explanation: Establishes nystagmus in the reviewed H-ABC cohort.
- name: Sensorineural Hearing Impairment
  subtype: H-ABC
  description: Sensorineural hearing impairment in a minority of H-ABC patients.
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  phenotype_contexts:
  - subtype: H-ABC
    frequency: 14%
    notes: Exact reviewed H-ABC frequency, 14% of 30 published patients.
    evidence:
    - reference: PMID:24706558
      reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        sensorineural hearing loss in 14%, and seizures in 18%
      explanation: Records the exact H-ABC hearing-impairment frequency.
  evidence:
  - reference: PMID:24706558
    reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      sensorineural hearing loss in 14%, and seizures in 18%
    explanation: Establishes sensorineural hearing impairment in H-ABC.
- name: Abnormal Basal Ganglia Morphology
  subtype: H-ABC
  description: >-
    Caudate and putaminal atrophy is a common progressive H-ABC pattern, often
    with preserved globus pallidus, but it is not obligatory. A p.Arg262His
    patient retained caudate and putaminal size over seven years, and mild
    thalamic atrophy in other patients precludes universal thalamic-sparing text.
  phenotype_term:
    preferred_term: Abnormal basal ganglia morphology
    term:
      id: HP:0002134
      label: Abnormal basal ganglia morphology
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:24706558
    reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In Patients 1 and 2, progressive atrophy of the head of the caudate was
      noted
    explanation: Supports progressive caudate atrophy in two followed patients.
  - reference: PMID:24706558
    reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In Patient 3, however, the size of the putamina and heads of the caudate
      remained stable between first and follow-up MR studies (Fig. 1J,L).
    explanation: Preserves the documented exception to progressive neostriatal atrophy.
- name: Dysphagia
  subtype: H-ABC
  description: Swallowing dysfunction from progressive bulbar involvement.
  phenotype_term:
    preferred_term: Dysphagia
    term:
      id: HP:0002015
      label: Dysphagia
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Swallowing dysfunction may require gastrostomy tube placement for feeding.
    explanation: Establishes swallowing dysfunction as the phenotype requiring feeding support.
- name: Dysphonia
  subtypes:
  - H-ABC
  - DYT-TUBB4A
  description: >-
    Impaired voice production occurs with H-ABC bulbar involvement and is a
    defining feature of DYT-TUBB4A; it is distinct from dysarthria.
  phenotype_term:
    preferred_term: Dysphonia
    term:
      id: HP:0001618
      label: Dysphonia
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      bulbar function (dysarthria, dysphonia, and swallowing)
    explanation: Names dysphonia among the bulbar findings.
  - reference: PMID:23595291
    reference_title: Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A mutation in TUBB4 causes DYT4 dystonia in this Australian family with
      so-called whispering dysphonia, and other mutations in TUBB4 may contribute
      to spasmodic dysphonia.
    explanation: Establishes the DYT-specific voice phenotype.
- name: Laryngeal Dystonia
  subtype: DYT-TUBB4A
  description: >-
    Dystonia prominently involving the larynx, producing whispering or spasmodic
    dysphonia in DYT-TUBB4A.
  phenotype_term:
    preferred_term: Laryngeal dystonia
    term:
      id: HP:0012049
      label: Laryngeal dystonia
  evidence:
  - reference: PMID:33084096
    reference_title: Whispering dysphonia in TUBB4A-related disorders responsive to bipallidal deep brain stimulation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report the case of a 44-year-old patient with DYT-TUBB4A with a clinical
      presentation of disabling progressive dystonia, with a prominent laryngeal,
      cervical and facial involvement.
    explanation: Directly establishes prominent laryngeal dystonia in DYT-TUBB4A.
- name: Rigidity
  subtype: H-ABC
  description: Extrapyramidal rigidity in the progressive H-ABC motor syndrome.
  phenotype_term:
    preferred_term: Rigidity
    term:
      id: HP:0002063
      label: Rigidity
  phenotype_contexts:
  - subtype: H-ABC
    frequency: 69%
    notes: Exact reviewed H-ABC frequency, 69% of 30 published patients.
    evidence:
    - reference: PMID:24706558
      reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Spasticity was present in 100% of patients, while ataxia was present in
        87%, choreoathetosis in 45%, dystonia in 88%, rigidity in 69%, and
        dysarthria in 93%
      explanation: Records the exact H-ABC rigidity frequency.
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      extrapyramidal system (rigidity, dystonia, choreoathetosis, oculogyric
      crisis, and perioral dyskinesia)
    explanation: Names rigidity among the extrapyramidal findings.
- name: Intention Tremor
  subtype: H-ABC
  description: Cerebellar intention tremor.
  phenotype_term:
    preferred_term: Intention tremor
    term:
      id: HP:0002080
      label: Intention tremor
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      cerebellum (ataxia, intention tremor, dysmetria)
    explanation: Names intention tremor among the cerebellar findings.
- name: Dysmetria
  subtype: H-ABC
  description: Cerebellar dysmetria.
  phenotype_term:
    preferred_term: Dysmetria
    term:
      id: HP:0001310
      label: Dysmetria
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      cerebellum (ataxia, intention tremor, dysmetria)
    explanation: Names dysmetria among the cerebellar findings.
genetic:
- name: TUBB4A
  association: Causative
  gene_term:
    preferred_term: TUBB4A (beta-tubulin 4A)
    term:
      id: hgnc:20774
      label: TUBB4A
  notes: >-
    TUBB4A encodes the brain-specific beta-tubulin 4A isotype. It is a pleiotropic
    locus in which heterozygous missense variants produce H-ABC, other pediatric
    hypomyelinating presentations, or DYT-TUBB4A. p.Arg2Trp and p.Asp249Asn have
    tested antimorphic effects; p.Gln424His alone has an explicit gain-of-function
    result; p.Arg2Gly lacks a prominent microtubule-dynamics defect. p.Cys239Phe
    and p.Arg262His are preserved as H-ABC alleles without importing a mechanism
    from the tested variants.
  evidence:
  - reference: PMID:35275727
    reference_title: H-ABC- and dystonia-causing TUBB4A mutations show distinct pathogenic effects.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Mutations in the brain-specific β-tubulin 4A (TUBB4A) gene cause a broad
      spectrum of diseases, ranging from dystonia (DYT-TUBB4A) to hypomyelination
      with atrophy of the basal ganglia and cerebellum (H-ABC).
    explanation: >-
      Establishes TUBB4A as causative across the full phenotypic spectrum this
      entry curates. This framing statement is a literature summary, so OTHER is
      used rather than HUMAN_CLINICAL.
  - reference: PMID:24706558
    reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A p.C239F mutation was found in one of the originally described H-ABC
      patients, for whom we provide follow-up 11 years after the original
      publication. The second novel mutation, p.R262H, was found in a patient
      with a typical clinical presentation for H-ABC
    explanation: >-
      Preserves both additional H-ABC alleles without assigning them the
      functional results measured for p.Arg2Trp or p.Asp249Asn.
  - reference: PMID:23595291
    reference_title: Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Genome sequencing revealed a missense variant in the TUBB4 (tubulin
      beta-4; Arg2Gly) gene as the likely cause of disease.
    explanation: Establishes the familial p.Arg2Gly DYT allele.
diagnosis:
- name: Brain magnetic resonance imaging
  description: >-
    MRI can identify hypomyelination and, in H-ABC, caudate, putaminal, or
    cerebellar atrophy. These findings raise suspicion but are not obligatory:
    an H-ABC p.Arg262His case lacked caudate and putaminal atrophy after seven
    years, and DYT-TUBB4A can have normal imaging. Molecular testing establishes
    the diagnosis.
  diagnosis_term:
    preferred_term: magnetic resonance imaging
    term:
      id: NCIT:C16809
      label: Magnetic Resonance Imaging
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The diagnosis is established in a proband with characteristic clinical
      and/or brain MRI findings and a heterozygous TUBB4A pathogenic variant
      identified by molecular genetic testing.
    explanation: Names MRI as part of the established diagnostic criterion.
  - reference: PMID:24706558
    reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Thus mutations in this gene should be suspected in any patient with
      hypomyelination, regardless of the long-term presence of neostriatal atrophy.
    explanation: >-
      Prevents neostriatal atrophy from being represented as a required imaging
      criterion.
- name: Molecular genetic testing
  description: >-
    Diagnosis is confirmed by a heterozygous pathogenic TUBB4A variant on
    molecular genetic testing.
  diagnosis_term:
    preferred_term: genetic testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      a heterozygous TUBB4A pathogenic variant identified by molecular genetic
      testing
    explanation: Names molecular testing as the confirmatory step.
progression:
- phase: Onset, spanning infancy to adulthood
  age_range: Infancy to adulthood
  notes: >-
    Onset age is the primary axis of the spectrum: early-infantile gives
    hypomyelination with developmental stagnation, encephalopathy, seizures and
    hypotonia; late-infantile gives acquisition then regression with dystonia;
    juvenile or adult onset gives milder disease including isolated dystonia.
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      TUBB4A-related neurologic disorders comprise a phenotypic spectrum ranging
      in onset from infancy to adulthood.
    explanation: States the onset range that structures the whole spectrum.
- phase: Progressive multi-system neurologic decline
  age_range: Variable, following onset
  notes: >-
    Pyramidal, extrapyramidal, cerebellar and bulbar systems become progressively
    involved. Rate of progression varies with disease severity. Cognition is
    variably affected and usually less severely than motor function - a point
    that matters for goal-setting, since communication and comprehension may
    substantially outrun motor capacity.
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Cognition is variably affected and is usually less severely affected than
      motor function. The rate of progression varies with disease severity.
    explanation: >-
      States both the cognitive-motor dissociation and the severity-dependent
      rate of progression.
clinical_burden:
  burden_level: HIGH
  rationale: >-
    High in pediatric-onset TUBB4A leukodystrophy. The infantile forms
    involve loss of ambulation, refractory dystonia, dysarthria and dysphonia
    requiring speech therapy and often gastrostomy, and lifelong dependence on
    adaptive equipment and multidisciplinary care. Surveillance requirements are
    substantial: swallowing and feeding evaluation to reduce aspiration risk,
    nutritional support, orthopaedic assessment for joint dislocation and
    scoliosis, and annual neurologic and cardiac review. The 58-caregiver burden
    study applies to pediatric-onset leukodystrophy and is not generalized to
    DYT-TUBB4A, whose burden profile can be materially different.
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Routine evaluations of swallowing and feeding to reduce the risk of
      aspiration; nutritional support to prevent malnutrition; orthopedic
      assessment to detect musculoskeletal issues including joint dislocations
      and scoliosis.
    explanation: >-
      The surveillance schedule is a direct measure of the ongoing care burden.
  - reference: PMID:41129987
    reference_title: "Critical Functional Domains in Pediatric Onset TUBB4A-Related Leukodystrophy: A Clinical and Caregiver's Perspective."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Overall, 58 caregivers participated in the study. The VABS-3 (n = 58)
      demonstrated a lesser impact on the Communication and Socialization Domains
      compared to Activities of Daily Living and Motor Domains
    explanation: >-
      Quantifies the pediatric-leukodystrophy functional burden; it is explicitly
      not evidence for the DYT-TUBB4A subtype.
treatments:
- name: Medical Management of Dystonia
  description: >-
    Individualized medical management for dystonia. GeneReviews does not name a
    specific agent, so none is inferred here. This symptomatic record is kept
    separate from deep brain stimulation.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  target_phenotypes:
  - preferred_term: Dystonia
    term:
      id: HP:0001332
      label: Dystonia
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Dystonia requires medical management and, when refractory to medical
      management, possibly surgical intervention.
    explanation: Supports medical management while leaving specific drug choice unstated.
- name: Bipallidal Deep Brain Stimulation for Refractory DYT-TUBB4A
  description: >-
    Bilateral pallidal deep brain stimulation reduced dystonia severity by 55%
    at six months in one 44-year-old patient with DYT-TUBB4A. This is a single
    case report, not evidence of general efficacy and not an H-ABC treatment.
  context: DYT-TUBB4A only; single adult case report after disabling refractory dystonia.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: Deep Brain Stimulation
    term:
      id: NCIT:C21024
      label: Deep Brain Stimulation
  target_phenotypes:
  - preferred_term: Dystonia
    term:
      id: HP:0001332
      label: Dystonia
  - preferred_term: Laryngeal dystonia
    term:
      id: HP:0012049
      label: Laryngeal dystonia
  evidence:
  - reference: PMID:33084096
    reference_title: Whispering dysphonia in TUBB4A-related disorders responsive to bipallidal deep brain stimulation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Bipallidal deep brain stimulation (DBS) resulted in a 55% reduction of
      dystonia severity assessed by the Burke-Fahn-Marsden scale score 6 months
      after surgery.
    explanation: >-
      Reports the case-level outcome; the single-patient design is retained in
      the treatment description and context.
- name: Adaptive Equipment and Physical Therapy for Spasticity
  description: >-
    Adaptive equipment such as wheelchairs and walkers plus physical therapy for
    functionally disabling spasticity, with prevention of secondary injury as
    the stated aim.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: physical therapy
    term:
      id: NCIT:C15302
      label: Physical Therapy
  target_phenotypes:
  - preferred_term: Spasticity
    term:
      id: HP:0001257
      label: Spasticity
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Functionally disabling spasticity may require adaptive equipment (e.g.,
      wheelchairs and walkers) and physical therapy to help prevent secondary
      injury.
    explanation: States the supportive management of the motor phenotype.
- name: Speech Therapy and Augmentative Communication
  description: >-
    Speech therapy with augmentative and alternative communication for
    dysarthria and dysphonia when speech becomes insufficient.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: speech and language therapy
    term:
      id: NCIT:C159273
      label: Speech Language Therapy
  target_phenotypes:
  - preferred_term: Dysarthria
    term:
      id: HP:0001260
      label: Dysarthria
  - preferred_term: Dysphonia
    term:
      id: HP:0001618
      label: Dysphonia
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Dysarthria and dysphonia require speech therapy and possible augmentative
      and alternative communication.
    explanation: Supports both the therapy and communication escalation.
- name: Gastrostomy Feeding for Swallowing Dysfunction
  description: >-
    Gastrostomy tube placement may be required when progressive swallowing
    dysfunction prevents safe oral feeding.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: gastrostomy
    term:
      id: NCIT:C52006
      label: Gastrostomy
  target_phenotypes:
  - preferred_term: Dysphagia
    term:
      id: HP:0002015
      label: Dysphagia
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Swallowing dysfunction may require gastrostomy tube placement for feeding.
    explanation: Supports gastrostomy for the swallowing phenotype.
- name: Multidisciplinary Surveillance
  description: >-
    Routine swallowing and feeding evaluation, nutritional support, orthopaedic
    assessment, and annual neurologic and cardiac review address complications
    of pediatric TUBB4A disease without modifying the causal mechanism.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Surveillance: Routine evaluations of swallowing and feeding to reduce the
      risk of aspiration; nutritional support to prevent malnutrition;
      orthopedic assessment to detect musculoskeletal issues including joint
      dislocations and scoliosis.
    explanation: Supports the feeding, nutrition, and orthopaedic surveillance schedule.
  - reference: PMID:27809427
    reference_title: TUBB4A-Related Neurologic Disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Annual neurologic assessment as well as cardiac evaluation to identify
      related complications.
    explanation: Supports the annual neurologic and cardiac components.
- name: Levodopa-Carbidopa and Trihexyphenidyl (Single-Patient Nonresponse)
  description: >-
    One H-ABC patient received levodopa/carbidopa and trihexyphenidyl without
    benefit. This narrowly records a case-level negative observation and does not
    establish class ineffectiveness or a treatment recommendation.
  context: H-ABC only; single patient; negative observation.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  target_phenotypes:
  - preferred_term: Dystonia
    term:
      id: HP:0001332
      label: Dystonia
  - preferred_term: Rigidity
    term:
      id: HP:0002063
      label: Rigidity
  evidence:
  - reference: PMID:24706558
    reference_title: Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      He was treated with levodopa/carbidopa and trihexyphenidyl without benefit,
      and is currently on baclofen for his increased muscle tone, with
      questionable effect.
    explanation: >-
      A single-patient nonresponse, explicitly not generalized to either drug
      class or the broader spectrum.
- name: Tubb4a-suppressing antisense oligonucleotide (preclinical)
  description: >-
    An H-ABC-specific preclinical strategy. The rationale
    comes from an allelic mouse series showing that disease severity correlates
    with mutant Tubb4a expression and with relative preservation of wild-type
    tubulin - so lowering the mutant transcript should help even without repairing
    it. A single intracerebroventricular dose of a Tubb4a-targeted ASO in
    postnatal Tubb4a D249N/KO mice drastically extended lifespan, improved motor
    phenotypes, reduced seizures, prevented myelin and oligodendrocyte loss, and
    recovered visual evoked potential latencies. A stated limitation is that the
    ASO fails to reach cerebellar granule neurons by any tested route, so the
    cerebellar arm of the disease may be untreated by this approach. There is no
    human trial; this must not be curated as an available therapy or extrapolated
    to DYT-TUBB4A.
  context: H-ABC p.Asp249Asn mouse models only; preclinical, not DYT-TUBB4A.
  therapeutic_modality: ANTISENSE_OLIGONUCLEOTIDE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  aso_details:
    aso_mechanism: RNASE_H_KNOCKDOWN
    target_gene:
      preferred_term: TUBB4A
      term:
        id: hgnc:20774
        label: TUBB4A
    target_transcript: Tubb4a mRNA
  target_mechanisms:
  - target: H-ABC Antimorphic Microtubule Dysfunction
    treatment_effect: INHIBITS
    description: >-
      Reducing Tubb4a transcript lowers the D249N mutant-subunit burden modeled
      at the H-ABC-specific trigger node.
    evidence:
    - reference: PMID:41566774
      reference_title: Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophy.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        we identified a well-tolerated Tubb4a-targeted antisense oligonucleotide
        (ASO) candidate that selectively reduces Tubb4a
      explanation: >-
        Establishes the agent and its mechanism of action on this node -
        selective reduction of the Tubb4a transcript.
  evidence:
  - reference: PMID:41566774
    reference_title: Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophy.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Notably, single intracerebroventricular administration of ASO in postnatal
      Tubb4aD249N/KO mice drastically extends its lifespan, improves motor
      phenotypes, and reduces seizures.
    explanation: >-
      Reports the efficacy readouts of the preclinical proof of concept.
  - reference: PMID:41566774
    reference_title: Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophy.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      A major limitation we noted is that ASOs fail to target cerebellar granule
      neurons even with multiple routes of administration in the brain.
    explanation: >-
      The authors' own stated limitation, recorded so the cerebellar gap is not
      lost when this strategy is cited.
  notes: >-
    Preclinical mouse proof-of-concept only as of 2026-08. The authors describe it
    as the first preclinical proof-of-concept for Tubb4a suppression via ASO as a
    disease-modifying therapy for H-ABC.
animal_models:
- name: Tubb4a D249N allelic mouse series
  species: Mouse
  genotype: Tubb4a KO/KO, D249N/+, D249N/KO and D249N/D249N
  publication: PMID:41566774
  description: >-
    An H-ABC p.Asp249Asn graded allelic series that establishes the dose relationship underpinning
    the therapeutic strategy: severity correlates with mutant Tubb4a expression
    and with relative preservation of wild-type tubulin. The D249N/KO animals
    provide the treatment substrate for the ASO experiment. It is not a model of
    DYT-TUBB4A.
  modeled_mechanisms:
  - target: H-ABC Antimorphic Microtubule Dysfunction
    relationship: RECAPITULATES
    fidelity: MODERATE
    description: >-
      Models the recurrent human H-ABC allele, and the allelic series isolates
      the mutant-to-wild-type ratio as the severity determinant.
    limitations: >-
      Severe phenotypes principally occur in D249N/D249N or D249N/null animals;
      the treated D249N/null genotype has no direct human equivalent. Mouse
      myelination timing and lifespan also differ from human, so the model is
      informative but not high fidelity.
    readouts:
    - name: Disease severity versus mutant Tubb4a expression
      target: H-ABC Antimorphic Microtubule Dysfunction
      direction: ALTERED
      interpretation: >-
        Severity scales with mutant expression and inversely with preserved
        wild-type tubulin.
      evidence:
      - reference: PMID:41566774
        reference_title: Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophy.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          we characterized a genetic murine series (Tubb4aKO/KO, Tubb4aD249N/+,
          Tubb4aD249N/KO, and Tubb4aD249N/D249N) to demonstrate that disease
          severity correlates with the expression of mutant Tubb4a and relative
          preservation of wild-type tubulin.
        explanation: Reports the dose-severity relationship measured across the series.
    evidence:
    - reference: PMID:41566774
      reference_title: Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophy.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        This is the first preclinical proof-of-concept for Tubb4a suppression via
        ASO as a disease-modifying therapy for H-ABC.
      explanation: >-
        The model is the basis of the only disease-modifying strategy reported
        for this disorder.
  - target: Oligodendrocyte Dysfunction and Myelin Failure
    relationship: RESCUES
    fidelity: MODERATE
    description: >-
      ASO treatment prevents myelin and oligodendrocyte loss and preserves Mbp
      mRNA transport, demonstrating the myelin arm is reversible in the model if
      the mutant burden is lowered early.
    limitations: >-
      Rescue is postnatal in a mouse whose myelination is largely postnatal; the
      equivalent human window is not established. Cerebellar granule neurons are
      not reached by the ASO.
    readouts:
    - name: Myelin and oligodendrocyte preservation under ASO
      target: Oligodendrocyte Dysfunction and Myelin Failure
      direction: RESTORED
      interpretation: >-
        Treatment prevents the myelin and oligodendrocyte loss that otherwise
        occurs.
      biological_processes:
      - preferred_term: myelination
        term:
          id: GO:0042552
          label: myelination
        modifier: DECREASED
      evidence:
      - reference: PMID:41566774
        reference_title: Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophy.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          Neuropathologically, treating ASO Tubb4aD249N/KO mice prevents myelin
          and oligodendrocyte (OL) loss and recovers visual evoked potential
          latencies in vivo.
        explanation: Reports the neuropathological and electrophysiological rescue.
    evidence:
    - reference: PMID:41566774
      reference_title: Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophy.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Furthermore, the microtubule function of Mbp mRNA transport from the OL
        soma to the myelin sheath is retained.
      explanation: >-
        Links the rescue back to the specific microtubule-dependent function this
        node curates.
- name: Tubb4a H-ABC mutant mouse (glial and neuronal degeneration)
  species: Mouse
  genotype: Tubb4a D249N/D249N
  publication: PMID:32463361
  description: >-
    An H-ABC-specific homozygous D249N model that degenerates both glia and
    neurons, providing evidence for curating the myelin and neurodegeneration arms as parallel
    branches rather than treating grey-matter atrophy as secondary to myelin
    failure. It does not model DYT-TUBB4A.
  modeled_mechanisms:
  - target: Basal Ganglia and Cerebellar Neurodegeneration
    relationship: RECAPITULATES
    fidelity: MODERATE
    description: >-
      Reproduces neuronal degeneration alongside the glial phenotype.
    limitations: >-
      The prominent phenotype is in homozygous D249N animals rather than the
      heterozygous human state. Regional correspondence and causal ordering of
      glial versus neuronal pathology therefore remain incomplete.
    evidence:
    - reference: PMID:32463361
      reference_title: TUBB4A mutations result in both glial and neuronal degeneration in an H-ABC leukodystrophy mouse model.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Additionally, a significant loss occurs in the cerebellar granular
        neurons and striatal neurons in Tubb4aD249N/D249N mice.
      explanation: >-
        Reports measured neuronal loss in striatum and cerebellar granule layer
        in the knock-in model.
discussions:
- discussion_id: gap_tubb4a_pleiotropy_mechanism
  prompt: >-
    Why do TUBB4A variants in the same gene produce either isolated adult-onset
    dystonia or infantile hypomyelinating leukodystrophy, and is a single
    functional_impact_category ever correct for this locus?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Altered Beta-Tubulin 4A (TUBB4A) Function
  - pathophysiology#H-ABC Antimorphic Microtubule Dysfunction
  - pathophysiology#DYT-TUBB4A-Associated Neuronal Dysfunction
  rationale: >-
    TUBB4A is the clearest pleiotropy problem in the tubulin family. Two
    observations pull in different directions. On one hand, the dystonia-causing
    variants (p.R2G, p.Q424H) and the H-ABC-causing variants (p.R2W, p.D249N) have
    demonstrably divergent effects on microtubule polymerization and on
    incorporation into the network in disease-relevant oligodendrocytes - which
    argues the two poles are mechanistically distinct, not one mechanism at two
    doses. Note the pointed detail that R2G and R2W affect the SAME residue and
    fall on opposite clinical poles. On the other hand, an allelic mouse series
    shows severity correlating cleanly with mutant expression and preserved
    wild-type tubulin, which is exactly what a single dose-dependent mechanism
    would look like. Both cannot be the whole story. The authors of the divergence
    study are careful to say the mechanisms explain the pleiotropy only
    "partially". Until this resolves, this entry records
    functional_impact_category as UNKNOWN rather than picking a value that would
    be wrong for half the alleles, and curators should not import a mechanism
    class from another tubulin gene by analogy.
  evidence:
  - reference: PMID:35275727
    reference_title: H-ABC- and dystonia-causing TUBB4A mutations show distinct pathogenic effects.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Here, we investigated whether TUBB4A mutations causing either DYT-TUBB4A
      (p.R2G and p.Q424H) or H-ABC (p.R2W and p.D249N) exhibit differential
      effects at the molecular and cellular levels.
    explanation: >-
      Names the allele pairs, including the two different substitutions at
      residue 2 that fall on opposite clinical poles.
  - reference: PMID:35275727
    reference_title: H-ABC- and dystonia-causing TUBB4A mutations show distinct pathogenic effects.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      In conclusion, for most of the examined variants, we deciphered potential
      molecular disease mechanisms that may lead to the diverse clinical
      manifestations and phenotype severity across and within each TUBB4A-related
      disease.
    explanation: >-
      The authors' own hedging - potential mechanisms, most variants - which is
      why this stays an open gap.
  - reference: PMID:41566774
    reference_title: Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophy.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      disease severity correlates with the expression of mutant Tubb4a and
      relative preservation of wild-type tubulin
    explanation: >-
      The dose-dependent evidence that pulls against a purely allele-specific
      mechanism model.
- discussion_id: gap_tubb4a_cerebellar_aso_gap
  prompt: >-
    Can a Tubb4a-suppressing ASO reach cerebellar granule neurons, and if not,
    does the cerebellar arm of H-ABC remain untreated by an otherwise effective
    therapy?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Basal Ganglia and Cerebellar Neurodegeneration
  rationale: >-
    The ASO proof-of-concept is striking on the myelin arm - extended lifespan,
    improved motor phenotypes, fewer seizures, preserved oligodendrocytes and
    myelin. But the authors flag one failure plainly: the ASO does not reach
    cerebellar granule neurons by any route of brain administration they tried.
    That matters more here than it would for a disorder with a single mechanism,
    because this entry curates cerebellar degeneration as a parallel arm rather
    than as a consequence of demyelination - the mouse work shows both glial and
    neuronal degeneration. If the arms are truly parallel, an intervention that
    rescues myelin and misses the cerebellum treats part of the disease, and the
    residual cerebellar phenotype would only become visible once the animals live
    long enough to show it. Resolving this needs either a delivery route that
    reaches granule neurons or long-term outcome data in treated animals with
    cerebellar-specific readouts.
  evidence:
  - reference: PMID:41566774
    reference_title: Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophy.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      A major limitation we noted is that ASOs fail to target cerebellar granule
      neurons even with multiple routes of administration in the brain.
    explanation: The stated delivery failure that defines this gap.
  - reference: PMID:32463361
    reference_title: TUBB4A mutations result in both glial and neuronal degeneration in an H-ABC leukodystrophy mouse model.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Additionally, a significant loss occurs in the cerebellar granular
      neurons and striatal neurons in Tubb4aD249N/D249N mice.
    explanation: >-
      Cerebellar granule neurons are specifically among the cells lost, which is
      what makes an ASO that cannot reach them consequential.
notes: >-
  Created 2026-08-20 while closing out the tubulin-family disease coverage gap
  identified in docs/reports/tubulinopathies-grouping-review-2026-08-20.md. That
  review named TUBB4A as deliberately out of scope for the Tubulinopathies
  grouping; this entry is the other half of that decision - out of the grouping,
  but not out of the knowledge base.

  Deliberately NOT a member of the Tubulinopathies grouping and NOT conformed to
  microtubule_dependent_neuronal_migration_failure. H-ABC is modeled with a
  postnatal oligodendrocyte/myelin arm and a parallel grey-matter arm, while
  DYT-TUBB4A has an independent cautious neuronal branch. Only the H-ABC myelin
  nodes conform to cns_myelin_failure; neither the grey-matter branch, the mixed
  clinical endpoint, nor the DYT branch conforms.

  functional_impact_category is UNKNOWN at the umbrella trigger by deliberate
  choice - see gap_tubb4a_pleiotropy_mechanism. The H-ABC p.Arg2Trp/p.Asp249Asn
  branch records the reported antimorphic effect, while p.Gln424His alone has an
  explicit gain-of-function result and p.Arg2Gly lacks a prominent dynamics
  change. No mechanism is imported to p.Cys239Phe or p.Arg262His.

  The taiep A302T rat has predominantly oligodendrocyte/white-matter abnormalities
  associated with greater microtubule stability, whereas the homozygous D249N
  mouse has both neuronal and glial degeneration. This model contrast is why the
  two H-ABC arms remain parallel and why neither animal allele is treated as a
  universal model of all TUBB4A disease.

  The ASO treatment is preclinical mouse work only. It is curated with
  target_mechanisms because it acts on a modeled node, but its status is stated in
  the treatment description, its notes, and the linked discussion. It is NOT
  conformed to the antisense_oligonucleotide_therapy module: per the repository's
  curation guidance, new conformance to that module's RNase-H knockdown branch is
  deferred pending a separate trigger/evidence audit.

  All evidence snippets are quoted from existing local reference-cache content,
  none from titles. No reference cache was fetched or edited for this review.
📚

References & Deep Research

References

10
PMID:27809427
TUBB4A-Related Neurologic Disorders.
No top-level findings curated for this source.
PMID:35275727
H-ABC- and dystonia-causing TUBB4A mutations show distinct pathogenic effects.
No top-level findings curated for this source.
PMID:24706558
Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
No top-level findings curated for this source.
PMID:28973395
TUBB4A mutations result in specific neuronal and oligodendrocytic defects that closely match clinically distinct phenotypes.
No top-level findings curated for this source.
PMID:23595291
Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene.
No top-level findings curated for this source.
PMID:33084096
Whispering dysphonia in TUBB4A-related disorders responsive to bipallidal deep brain stimulation.
No top-level findings curated for this source.
PMID:41566774
Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophy.
No top-level findings curated for this source.
PMID:32463361
TUBB4A mutations result in both glial and neuronal degeneration in an H-ABC leukodystrophy mouse model.
No top-level findings curated for this source.
PMID:42044700
H-ABC tubulinopathy exhibits a cytoskeletal defect associated with microtubule stability.
No top-level findings curated for this source.
PMID:41129987
Critical Functional Domains in Pediatric Onset TUBB4A-Related Leukodystrophy: A Clinical and Caregiver's Perspective.
No top-level findings curated for this source.